Glycation-induced modification of tissue-specific ECM proteins: A pathophysiological mechanism in degenerative diseases
Glycation driven generation of advanced glycation end products (AGEs) and their patho-physiological role in human degenerative diseases has remained one of the thrust areas in the mainstream of disease biology. Glycation of extracellular matrix (ECM) proteins have deleterious effect on the mechanica...
Saved in:
| Published in | Biochimica et biophysica acta. General subjects Vol. 1863; no. 11; p. 129411 |
|---|---|
| Main Authors | , |
| Format | Journal Article |
| Language | English |
| Published |
Netherlands
Elsevier B.V
01.11.2019
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Glycation driven generation of advanced glycation end products (AGEs) and their patho-physiological role in human degenerative diseases has remained one of the thrust areas in the mainstream of disease biology. Glycation of extracellular matrix (ECM) proteins have deleterious effect on the mechanical and functional properties of tissues. Owing to the adverse pathophysiological concerns of glycation, there is a need to decipher the underlying mechanisms.
AGE-modified ECM proteins affect the cell in the vicinity by altering protein structure-function, matrix-matrix or matrix-cell interaction and by activating signalling pathway through receptor for AGE. This review is intended for addressing the AGE-induced modification of tissue-specific ECM proteins and its implication in the pathogenesis of various organ-specific human ailments.
The glycation affects the canonical cell behaviour due to alteration in the interaction of glycated ECM with receptors like integrins and discodin domain, and the signalling cues generated subsequently affect the downstream signalling pathways. Consequently, the variation of structural and functional properties of tissues due to matrix glycation helps in the initiation or progression of the disease condition.
This review offers comprehensive knowledge about the remodelling of glycation induced ECM and tissue-specific pathological concerns. As glycation of ECM affects the normal tissues and cell behaviour, the scientific discourse may also provide cues for developing candidate drugs that may help in attenuating the adverse effects of AGEs and perhaps open a research window of tailoring novel strategies for the management of glycation induced human degenerative diseases.
•ECM glycation alters the physiology of cellular growth, proliferation, migration and cell signalling pathways.•ECM Glycation adversely affects the neuronal system, lung homeostasis, cardiac system, bone metabolism, and renal function.•Glycated bone ECM influence bone remodelling and fragility.•There is need to develop glycation and AGE targeted therapeutic modalities. |
|---|---|
| AbstractList | Glycation driven generation of advanced glycation end products (AGEs) and their patho-physiological role in human degenerative diseases has remained one of the thrust areas in the mainstream of disease biology. Glycation of extracellular matrix (ECM) proteins have deleterious effect on the mechanical and functional properties of tissues. Owing to the adverse pathophysiological concerns of glycation, there is a need to decipher the underlying mechanisms.AGE-modified ECM proteins affect the cell in the vicinity by altering protein structure-function, matrix-matrix or matrix-cell interaction and by activating signalling pathway through receptor for AGE. This review is intended for addressing the AGE-induced modification of tissue-specific ECM proteins and its implication in the pathogenesis of various organ-specific human ailments.The glycation affects the canonical cell behaviour due to alteration in the interaction of glycated ECM with receptors like integrins and discodin domain, and the signalling cues generated subsequently affect the downstream signalling pathways. Consequently, the variation of structural and functional properties of tissues due to matrix glycation helps in the initiation or progression of the disease condition.This review offers comprehensive knowledge about the remodelling of glycation induced ECM and tissue-specific pathological concerns. As glycation of ECM affects the normal tissues and cell behaviour, the scientific discourse may also provide cues for developing candidate drugs that may help in attenuating the adverse effects of AGEs and perhaps open a research window of tailoring novel strategies for the management of glycation induced human degenerative diseases. Glycation driven generation of advanced glycation end products (AGEs) and their patho-physiological role in human degenerative diseases has remained one of the thrust areas in the mainstream of disease biology. Glycation of extracellular matrix (ECM) proteins have deleterious effect on the mechanical and functional properties of tissues. Owing to the adverse pathophysiological concerns of glycation, there is a need to decipher the underlying mechanisms.BACKGROUNDGlycation driven generation of advanced glycation end products (AGEs) and their patho-physiological role in human degenerative diseases has remained one of the thrust areas in the mainstream of disease biology. Glycation of extracellular matrix (ECM) proteins have deleterious effect on the mechanical and functional properties of tissues. Owing to the adverse pathophysiological concerns of glycation, there is a need to decipher the underlying mechanisms.AGE-modified ECM proteins affect the cell in the vicinity by altering protein structure-function, matrix-matrix or matrix-cell interaction and by activating signalling pathway through receptor for AGE. This review is intended for addressing the AGE-induced modification of tissue-specific ECM proteins and its implication in the pathogenesis of various organ-specific human ailments.SCOPE OF REVIEWAGE-modified ECM proteins affect the cell in the vicinity by altering protein structure-function, matrix-matrix or matrix-cell interaction and by activating signalling pathway through receptor for AGE. This review is intended for addressing the AGE-induced modification of tissue-specific ECM proteins and its implication in the pathogenesis of various organ-specific human ailments.The glycation affects the canonical cell behaviour due to alteration in the interaction of glycated ECM with receptors like integrins and discodin domain, and the signalling cues generated subsequently affect the downstream signalling pathways. Consequently, the variation of structural and functional properties of tissues due to matrix glycation helps in the initiation or progression of the disease condition.MAJOR CONCLUSIONSThe glycation affects the canonical cell behaviour due to alteration in the interaction of glycated ECM with receptors like integrins and discodin domain, and the signalling cues generated subsequently affect the downstream signalling pathways. Consequently, the variation of structural and functional properties of tissues due to matrix glycation helps in the initiation or progression of the disease condition.This review offers comprehensive knowledge about the remodelling of glycation induced ECM and tissue-specific pathological concerns. As glycation of ECM affects the normal tissues and cell behaviour, the scientific discourse may also provide cues for developing candidate drugs that may help in attenuating the adverse effects of AGEs and perhaps open a research window of tailoring novel strategies for the management of glycation induced human degenerative diseases.GENERAL SIGNIFICANCEThis review offers comprehensive knowledge about the remodelling of glycation induced ECM and tissue-specific pathological concerns. As glycation of ECM affects the normal tissues and cell behaviour, the scientific discourse may also provide cues for developing candidate drugs that may help in attenuating the adverse effects of AGEs and perhaps open a research window of tailoring novel strategies for the management of glycation induced human degenerative diseases. Glycation driven generation of advanced glycation end products (AGEs) and their patho-physiological role in human degenerative diseases has remained one of the thrust areas in the mainstream of disease biology. Glycation of extracellular matrix (ECM) proteins have deleterious effect on the mechanical and functional properties of tissues. Owing to the adverse pathophysiological concerns of glycation, there is a need to decipher the underlying mechanisms. AGE-modified ECM proteins affect the cell in the vicinity by altering protein structure-function, matrix-matrix or matrix-cell interaction and by activating signalling pathway through receptor for AGE. This review is intended for addressing the AGE-induced modification of tissue-specific ECM proteins and its implication in the pathogenesis of various organ-specific human ailments. The glycation affects the canonical cell behaviour due to alteration in the interaction of glycated ECM with receptors like integrins and discodin domain, and the signalling cues generated subsequently affect the downstream signalling pathways. Consequently, the variation of structural and functional properties of tissues due to matrix glycation helps in the initiation or progression of the disease condition. This review offers comprehensive knowledge about the remodelling of glycation induced ECM and tissue-specific pathological concerns. As glycation of ECM affects the normal tissues and cell behaviour, the scientific discourse may also provide cues for developing candidate drugs that may help in attenuating the adverse effects of AGEs and perhaps open a research window of tailoring novel strategies for the management of glycation induced human degenerative diseases. Glycation driven generation of advanced glycation end products (AGEs) and their patho-physiological role in human degenerative diseases has remained one of the thrust areas in the mainstream of disease biology. Glycation of extracellular matrix (ECM) proteins have deleterious effect on the mechanical and functional properties of tissues. Owing to the adverse pathophysiological concerns of glycation, there is a need to decipher the underlying mechanisms. AGE-modified ECM proteins affect the cell in the vicinity by altering protein structure-function, matrix-matrix or matrix-cell interaction and by activating signalling pathway through receptor for AGE. This review is intended for addressing the AGE-induced modification of tissue-specific ECM proteins and its implication in the pathogenesis of various organ-specific human ailments. The glycation affects the canonical cell behaviour due to alteration in the interaction of glycated ECM with receptors like integrins and discodin domain, and the signalling cues generated subsequently affect the downstream signalling pathways. Consequently, the variation of structural and functional properties of tissues due to matrix glycation helps in the initiation or progression of the disease condition. This review offers comprehensive knowledge about the remodelling of glycation induced ECM and tissue-specific pathological concerns. As glycation of ECM affects the normal tissues and cell behaviour, the scientific discourse may also provide cues for developing candidate drugs that may help in attenuating the adverse effects of AGEs and perhaps open a research window of tailoring novel strategies for the management of glycation induced human degenerative diseases. •ECM glycation alters the physiology of cellular growth, proliferation, migration and cell signalling pathways.•ECM Glycation adversely affects the neuronal system, lung homeostasis, cardiac system, bone metabolism, and renal function.•Glycated bone ECM influence bone remodelling and fragility.•There is need to develop glycation and AGE targeted therapeutic modalities. |
| ArticleNumber | 129411 |
| Author | Gacche, Rajesh N. Bansode, Sneha B. |
| Author_xml | – sequence: 1 givenname: Sneha B. surname: Bansode fullname: Bansode, Sneha B. email: bansodesneha30@gmail.com – sequence: 2 givenname: Rajesh N. surname: Gacche fullname: Gacche, Rajesh N. email: rngacche@unipune.ac.in |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31400438$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkcFu1DAURS1URKcDf4CQl2wS7NhJnC6QqlFpkYrYwNpy7JeOR4kdbKfV_D2eprBgQb2x9HTu1dM7F-jMeQcIvaekpIQ2nw5l36t7cGVFaFcSURLCX6ENFW1VCEKaM7QhjPCC06Y-RxcxHkh-dVe_QeeM8kwzsUGPN-NRq2S9K6wziwaDJ2_sYNch9gNONsYFijiDPs3x9e4bnoNPYF28xFd4Vmnv5_0xWj_6-xwc8QR6r5yNE7YOG8hbQsh9D4CNjaAixLfo9aDGCO-e_y36-eX6x-62uPt-83V3dVdo1tWpUG2lmobW3NQ9obyGig8NrQQxlaBc97XWLaMGasY701Xd0AoA1nAgnW5037Mt-rj25o1_LRCTnGzUMI7KgV-irJgQbUc5ZS-jVUsFJ01LMvrhGV36CYycg51UOMo_d80AXwEdfIwBhr8IJfKkTx7kqk-e9Eki5Cm4RZf_xLRNTyJSUHZ8Kfx5DUO-54OFIKO24LJSG0Anabz9f8FvaNe4wg |
| CitedBy_id | crossref_primary_10_1016_j_bios_2025_117316 crossref_primary_10_1080_14789450_2024_2427136 crossref_primary_10_3390_ijms232314916 crossref_primary_10_4239_wjd_v12_i5_590 crossref_primary_10_1155_2022_7119256 crossref_primary_10_1111_jcmm_15552 crossref_primary_10_1093_cvr_cvac175 crossref_primary_10_3390_ijms22179367 crossref_primary_10_3390_biomedicines10010057 crossref_primary_10_1007_s10522_024_10172_0 crossref_primary_10_1016_j_heliyon_2023_e18239 crossref_primary_10_1111_jfbc_13967 crossref_primary_10_3390_ijms232315237 crossref_primary_10_3390_jcm10204792 crossref_primary_10_1016_j_cellsig_2023_110916 crossref_primary_10_3390_cells8111320 crossref_primary_10_1038_s41580_024_00767_3 crossref_primary_10_1093_glycob_cwac060 crossref_primary_10_1016_j_cellsig_2019_109487 crossref_primary_10_1016_j_mbplus_2020_100037 crossref_primary_10_1111_1541_4337_13412 crossref_primary_10_1016_j_joim_2021_12_003 crossref_primary_10_1089_ten_tec_2020_0331 crossref_primary_10_3390_app11104495 crossref_primary_10_1186_s12933_024_02369_x crossref_primary_10_3390_cells11020240 crossref_primary_10_1186_s12958_021_00760_x crossref_primary_10_3390_nu16193282 |
| Cites_doi | 10.1016/j.matbio.2016.01.001 10.1016/j.jns.2012.02.018 10.1038/ki.1994.405 10.2337/diab.42.4.509 10.1007/s10741-013-9374-y 10.1093/ndt/gfg200 10.1016/j.biocel.2003.09.006 10.1007/s00395-017-0646-x 10.1016/j.bone.2006.09.011 10.1055/s-0029-1210738 10.1038/414813a 10.1159/000108104 10.1172/JCI115204 10.1161/CIRCHEARTFAILURE.113.000440 10.1007/s10741-010-9225-z 10.1038/nrn3550 10.1016/j.diabet.2008.08.001 10.1097/01.ASN.0000132474.50966.DA 10.1016/j.addr.2010.08.011 10.1016/j.mad.2016.03.004 10.1016/j.matbio.2017.06.004 10.1016/j.biomaterials.2009.04.005 10.1007/s00394-007-0644-0 10.2174/1389201011208062532 10.1007/s00401-006-0124-2 10.1016/j.bone.2013.10.001 10.1002/prca.201500030 10.1016/j.bbadis.2014.07.008 10.1369/0022155412465073 10.1038/jcbfm.2011.98 10.2337/diab.41.2.S49 10.1016/0021-9150(92)90132-Z 10.1016/j.mvr.2004.04.002 10.1152/ajpheart.00168.2002 10.2337/db05-1634 10.1097/01.hco.0000127135.73849.4f 10.1007/s00401-002-0524-x 10.1042/bst022399s 10.1515/cclm-2012-0818 10.1007/s12079-011-0137-z 10.1007/BF00403914 10.1152/ajprenal.00398.2004 10.1111/bph.12656 10.1016/S1995-7645(13)60097-8 10.1164/rccm.201202-0282PP 10.2337/db11-1120 10.2337/db09-0320 10.1042/BST0350656 10.1016/S0002-9440(10)65155-3 10.1016/j.ejheart.2007.09.009 10.1042/bj3440109 10.1196/annals.1333.093 10.1016/j.ab.2017.02.011 10.1016/j.bone.2011.04.009 10.1016/j.jvs.2016.04.028 10.1023/A:1021660105893 10.1111/j.1527-5299.2004.03223.x 10.1155/2012/598638 10.1093/cvr/cvw061 10.1242/jcs.018093 10.1177/1479164118780799 10.1016/j.biopha.2004.09.004 10.2337/diabetes.54.10.2952 10.2174/138161209787846739 10.1002/jbm.b.31551 10.1155/2013/653789 10.1016/j.fct.2010.04.048 10.1002/mnfr.200700101 10.1002/prca.201200101 10.1016/S0006-2952(99)00263-4 10.3109/07853899608999102 10.1038/ki.1995.322 10.1681/ASN.2008080900 10.1183/13993003.01805-2016 10.1046/j.1523-1755.2000.07711.x 10.1016/j.yexcr.2012.02.031 10.1161/CIRCRESAHA.114.302533 10.1007/s00125-004-1392-9 10.1042/CS20160025 10.2337/diabetes.48.7.1443 10.1172/JCI8040 10.1002/jbmr.5650110709 10.1161/CIRCULATIONAHA.108.777326 10.1002/dneu.20974 10.1097/00004872-200301000-00002 10.1002/dneu.20954 10.1007/s004150200033 10.1159/000369310 10.2174/138161209787846757 10.1016/j.exger.2012.04.012 10.1007/BF00175658 10.1074/jbc.M006700200 10.1007/s00441-009-0829-3 10.1038/srep02941 10.1016/j.jprot.2013.05.012 10.1016/S0021-9150(01)00521-4 10.1016/j.matbio.2006.10.007 10.1186/1471-2121-2-16 10.1159/000075627 10.1111/j.1750-3639.2008.00195.x 10.1302/2046-3758.71.BJR-2017-0135.R1 10.1016/j.ijcard.2016.02.095 10.1111/j.1525-139X.2009.00589.x 10.2165/11315260-000000000-00000 10.2337/diabetes.51.8.2612 10.1111/j.1365-2613.2011.00787.x 10.1186/1755-1536-7-4 10.1097/FJC.0b013e3181ac3a34 10.2337/diab.46.5.895 10.1016/S0021-9258(18)31635-1 10.1111/j.1476-5381.2009.00309.x 10.1186/1758-5996-4-19 10.7554/eLife.36354 10.1159/000334668 10.1016/S0006-291X(88)80463-7 10.1016/j.bone.2006.12.056 10.1371/journal.pone.0204171 10.3109/13880209.2014.895389 10.1080/17476348.2018.1460206 10.1073/pnas.91.24.11704 10.1007/s00198-014-2938-4 10.1074/mcp.M112.020651 10.1242/jcs.023820 10.1007/s00223-016-0153-3 |
| ContentType | Journal Article |
| Copyright | 2019 Elsevier B.V. Copyright © 2019 Elsevier B.V. All rights reserved. |
| Copyright_xml | – notice: 2019 Elsevier B.V. – notice: Copyright © 2019 Elsevier B.V. All rights reserved. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 7S9 L.6 |
| DOI | 10.1016/j.bbagen.2019.08.004 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
| DatabaseTitleList | AGRICOLA MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Chemistry Biology |
| EISSN | 1872-8006 |
| ExternalDocumentID | 31400438 10_1016_j_bbagen_2019_08_004 S0304416519301977 |
| Genre | Journal Article Review |
| GroupedDBID | --- --K --M .~1 0R~ 1B1 1RT 1~. 1~5 23N 3O- 4.4 457 4G. 53G 5GY 5RE 5VS 7-5 71M 8P~ 9JM AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AAXUO ABEFU ABFNM ABGSF ABMAC ABUDA ABXDB ABYKQ ACDAQ ACIUM ACRLP ADBBV ADEZE ADMUD ADUVX AEBSH AEHWI AEKER AFKWA AFTJW AFXIZ AGHFR AGRDE AGUBO AGYEJ AHHHB AIEXJ AIKHN AITUG AJBFU AJOXV ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC CS3 DOVZS EBS EFJIC EFLBG EJD EO8 EO9 EP2 EP3 FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HLW HVGLF HZ~ IHE J1W KOM LX3 M41 MO0 N9A O-L O9- OAUVE OHT OZT P-8 P-9 PC. Q38 R2- ROL RPZ SBG SCC SDF SDG SDP SES SEW SPCBC SSU SSZ T5K UQL WH7 WUQ XJT XPP ~G- AAHBH AATTM AAXKI AAYWO AAYXX ABWVN ACRPL ACVFH ADCNI ADNMO AEIPS AEUPX AFJKZ AFPUW AGCQF AGQPQ AGRNS AIGII AIIUN AKBMS AKRWK AKYEP ANKPU APXCP BNPGV CITATION SSH CGR CUY CVF ECM EIF NPM 7X8 7S9 EFKBS L.6 |
| ID | FETCH-LOGICAL-c395t-a72a66154d5b0145e24f61280d2814cb5cc731de5349d929f78ee364e09c6cbb3 |
| IEDL.DBID | .~1 |
| ISSN | 0304-4165 1872-8006 |
| IngestDate | Mon Jul 21 10:18:56 EDT 2025 Fri Jul 11 00:09:45 EDT 2025 Wed Feb 19 02:30:27 EST 2025 Tue Jul 01 00:22:12 EDT 2025 Thu Apr 24 22:54:42 EDT 2025 Fri Feb 23 02:34:14 EST 2024 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 11 |
| Keywords | Extracellular matrix RAGE Degenerative diseases Protein glycation Cellular signalling |
| Language | English |
| License | Copyright © 2019 Elsevier B.V. All rights reserved. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c395t-a72a66154d5b0145e24f61280d2814cb5cc731de5349d929f78ee364e09c6cbb3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
| PMID | 31400438 |
| PQID | 2271840670 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_2388791413 proquest_miscellaneous_2271840670 pubmed_primary_31400438 crossref_primary_10_1016_j_bbagen_2019_08_004 crossref_citationtrail_10_1016_j_bbagen_2019_08_004 elsevier_sciencedirect_doi_10_1016_j_bbagen_2019_08_004 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2019-11-01 |
| PublicationDateYYYYMMDD | 2019-11-01 |
| PublicationDate_xml | – month: 11 year: 2019 text: 2019-11-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | Netherlands |
| PublicationPlace_xml | – name: Netherlands |
| PublicationTitle | Biochimica et biophysica acta. General subjects |
| PublicationTitleAlternate | Biochim Biophys Acta Gen Subj |
| PublicationYear | 2019 |
| Publisher | Elsevier B.V |
| Publisher_xml | – name: Elsevier B.V |
| References | Jacob, Shastry, Sudhakaran (bb0125) 2001; 159 Xian, Gopal, Couchman (bb0070) 2010; 339 Hollenbach, Thampi, Viswanathan, Abraham (bb0590) 2003; 243 Hipkiss, Michaelis, Syrris, Kumar, Lam (bb0525) 1994; 22 Simm (bb0290) 2013; 92 Mendez, Leal (bb0520) 2004; 58 Gentili, Cancedda (bb0450) 2009; 15 Bolton, Cattran, Williams, Adler, Appel, Cartwright, Foiles, Freedman, Raskin, Ratner, Spinowitz, Whittier, Wuerth (bb0565) 2004; 24 Verzijl, DeGroot, Thorpe, Bank, Shaw, Lyons, Bijlsma, Lafeber, Baynes, TeKoppele (bb0040) 2000; 275 Perez Gutierrez, de Jesus Martinez Ortiz (bb0630) 2014; 52 Valencia, Mone, Koehne, Rediske, Hughes (bb0025) 2004; 47 Chandra, Shiwalkar, Kotecha, Thakkar, Srivastava, Chauthaiwale, Sharma, Cross, Dutt (bb0610) 2009; 29 Bohlender, Franke, Stein, Wolf (bb0385) 2005; 289 Engelhardt (bb0210) 2011; 31 Rao, Cotlier (bb0530) 1988; 151 Sakata, Noma, Yamamoto, Okamoto, Meng, Takebayashi, Nagai, Horiuchi (bb0115) 2003; 18 Bodiga, Eda, Bodiga (bb0300) 2014; 19 Reddy (bb0105) 2004; 68 Joshi, Gupta, Dubey, Shiwalkar, Pathak, Gupta, Chauthaiwale, Dutt (bb0605) 2009; 54 Jones, Andriotis, Roberts, Lunn, Tear, Cao, Ask, Smart, Bonfanti, Johnson, Alzetani, Conforti, Doherty, Lai, Johnson, Bourdakos, Fletcher, Marshall, Jogai, Brereton, Chee, Ottensmeier, Sime, Gauldie, Kolb, Mahajan, Fabre, Bhaskar, Jarolimek, Richeldi, O’Reilly, Monk, Thurner, Davies (bb0245) 2018; 7 Janssen, Piscaer, Wouters (bb0260) 2018; 12 Dobler, Ahmed, Song, Eboigbodin, Thornalley (bb0350) 2006; 55 McCarthy, Uemura, Etcheverry, Cortizo (bb0480) 2004; 36 Dattani, Sayers, Bown (bb0145) 2018; 15 Williams, Bolton, Khalifah, Degenhardt, Schotzinger, McGill (bb0570) 2007; 27 Brownlee (bb0015) 2001; 414 Rabbani, Xue, Thornalley (bb0340) 2016; 130 Vlassara (bb0120) 1996; 28 Zieman, Kass (bb0295) 2004; 10 Lo, Westwood, McLellan, Selwood, Thornalley (bb0415) 1994; 269 Luo, King, Lewin, Thomas (bb0180) 2002; 249 Tiengo, Fadini, Avogaro (bb0240) 2008; 34 Duca, Blaise, Romier, Laffargue, Gayral, El Btaouri, Kawecki, Guillot, Martiny, Debelle, Maurice (bb0250) 2016; 110 Powell, Vine, Crossman (bb0090) 1992; 97 McLennan, Martell, Yue (bb0435) 2002; 51 Xu, Shi (bb0085) 2014; 1842 Correa-Giannella, de Azevedo, Leroith, Giannella-Neto (bb0135) 2012; 4 Czuriga, Paulus, Czuriga, Edes, Papp, Borbely (bb0325) 2012; 13 Rascher, Fischmann, Kroger, Duffner, Grote, Wolburg (bb0200) 2002; 104 Endemann, Schiffrin (bb0430) 2004; 15 Hartog, Voors, Bakker, Smit, van Veldhuisen (bb0305) 2007; 9 Perez Gutierrez (bb0620) 2012; 2012 Katayama, Akatsu, Yamamoto, Kugai, Nagata (bb0470) 1996; 11 Blackburn, Vulesevic, McNeill, Cimenci, Ahmadi, Gonzalez-Gomez, Ostojic, Zhong, Brownlee, Beisswenger, Milne, Suuronen (bb0345) 2017; 112 Willemsen, Hartog, Heiner-Fokkema, van Veldhuisen, Voors (bb0285) 2012; 17 Miner (bb0360) 2012; 318 LeWinter, Taatjes, Ashikaga, Palmer, Bishop, VanBuren, Bell, Donaldson, Meyer, Margulies, Redfield, Bull, Zile (bb0330) 2017; 5 Bansode, Chougale, Joshi, Giri, Bodhankar, Harsulkar, Kulkarni (bb0010) 2013; 12 Ural, Janeiro, Karim, Diab, Vashishth (bb0460) 2015; 26 Voziyan, Hudson (bb0550) 2005; 1043 Shapiro, Endicott, Province, Pierce, Campbell (bb0045) 1991; 87 Hussain, Bork, Gnanapragassam, Bennmann, Jacobs, Navarette-Santos, Hofmann, Simm, Danker, Horstkorte (bb0205) 2016; 155 Fujimoto, Hastings, Carrick-Ranson, Shafer, Shibata, Bhella, Abdullah, Barkley, Adams-Huet, Boyd, Livingston, Palmer, Levine (bb0600) 2013; 6 Ehrlich, Hanke, Simon, Born, Fischer, Frolov, Langrock, Hoffmann, Schwarzenbolz, Henle, Bazhenov, Worch (bb0465) 2010; 92 Thornalley, Langborg, Minhas (bb0005) 1999; 344 Koole, van Herwaarden, Schalkwijk, Lafeber, Vink, Smeets, Pasterkamp, Moll (bb0140) 2017; 65 Zhang, He, Bharadwaj, Hammam, Carnagey, Myers, Atala, Van Dyke (bb0080) 2009; 30 Abar, Dharmar, Tang (bb0555) 2018; 7 Deluyker, Ferferieva, Noben, Swennen, Bronckaers, Lambrichts, Rigo, Bito (bb0335) 2016; 210 Thornalley, Rabbani (bb0375) 2009; 22 Faner, Rojas, Macnee, Agusti (bb0225) 2012; 186 Di Petta, Greco, Castro, Lopes, Martins, Capelozzi, Moreira, Sannomiya (bb0255) 2011; 92 Kesavan, Bhat, Golegaonkar, Jagadeeshaprasad, Deshmukh, Patil, Bhosale, Shaikh, Thulasiram, Boppana, Kulkarni (bb0535) 2013; 3 McCarthy, Etcheverry, Bruzzone, Lettieri, Barrio, Cortizo (bb0475) 2001; 2 Aronson (bb0355) 2003; 21 Khosravi, Sodek, Faibish, Trackman (bb0490) 2014; 58 Baeten, Akassoglou (bb0195) 2011; 71 Lau, Cua, Keough, Haylock-Jacobs, Yong (bb0150) 2013; 14 Rauch (bb0160) 2007; 35 Thomas, Cleland, Zhang, Gundberg, Vashishth (bb0515) 2017; 525 Kwok, Dick, Wang, Fawcett (bb0155) 2011; 71 Makino, Shikata, Hironaka, Kushiro, Yamasaki, Sugimoto, Ota, Araki, Horiuchi (bb0395) 1995; 48 Leitinger, Hohenester (bb0065) 2007; 26 Duran-Jimenez, Dobler, Moffatt, Rabbani, Streuli, Thornalley, Tomlinson, Gardiner (bb0035) 2009; 58 Tang, Zeenath, Vashishth (bb0455) 2007; 40 Charonis, Tsilbary (bb0075) 1992; 41 Bellmunt, Portero, Pamplona, Muntaner, Prat (bb0230) 1995; 173 Urios, Grigorova-Borsos, Sternberg (bb0635) 2007; 46 Rienks, Papageorgiou, Frangogiannis, Heymans (bb0270) 2014; 114 Mooney, Jackson, Bacon, Streuli, Edwards, Bassuk, Savill (bb0405) 1999; 155 Kulkarni, Korwar, Mary, Bhonsle, Giri (bb0030) 2013; 7 Pedchenko, Chetyrkin, Chuang, Ham, Saleem, Mathieson, Hudson, Voziyan (bb0425) 2005; 54 Harburger, Calderwood (bb0060) 2009; 122 Frantz, Stewart, Weaver (bb0050) 2010; 123 Sell, Monnier (bb0100) 2012; 58 Jagtap, Patil (bb0625) 2010; 48 McDonald, Coleman, Bhatwadekar, Gardiner, Stitt (bb0215) 2009; 15 Arias, Herrero, Echeverri, Oleaga, Lopez (bb0445) 2018; 13 Ozturk, Sekeroglu, Erdogan, Ozturk (bb0185) 2006; 112 Herrmann, McCulloch, Omens (bb0315) 2003; 284 Makino, Sugiyama, Kashihara (bb0400) 2000; 77 Nakamura, Makita, Ishikawa, Yasumura, Fujii, Yanagisawa, Kawata, Koike (bb0545) 1997; 46 Sims, Rasmussen, Oxlund, Bailey (bb0110) 1996; 39 Li, Liu, Sun, Lu, Zhang (bb0170) 2012; 317 Watkins, Gayle, Alsanjari, Scaravilli, Zanone, Thomas (bb0175) 1995; 88 Alikhani, Alikhani, Boyd, MacLellan, Raptis, Liu, Pischon, Trackman, Gerstenfeld, Graves (bb0495) 2007; 40 Chang, Dalgliesh, Lopez, Griffiths (bb0265) 2016; 10 Ramkissoon, Mahomoodally, Ahmed, Subratty (bb0615) 2013; 6 Panwar, Butler, Jamroz, Azizi, Overall, Bromme (bb0510) 2018; 65 Nagai, Murray, Metz, Baynes (bb0580) 2012; 61 Avendano, Agarwal, Bashey, Lyons, Soni, Jyothirmayi, Regan (bb0310) 1999; 48 Wang, McLennan, Twigg (bb0440) 2011; 5 Trackman (bb0485) 2016; 52–54 Eble, Niland (bb0095) 2009; 15 Vlassara, Striker, Teichberg, Fuh, Li, Steffes (bb0380) 1994; 91 Ruggiero-Lopez, Lecomte, Moinet, Patereau, Lagarde, Wiernsperger (bb0540) 1999; 58 Shapiro, Owan, Mohammed, Meyer, Mills, Schalkwijk, Redfield (bb0320) 2008; 118 Yang, Mostafa, Appleford, Sun, Wang (bb0500) 2016; 99 Krantz, Lober, Thiele, Teuscher (bb0130) 1988; 91 Federoff, Lawrence, Brownlee (bb0190) 1993; 42 Kolset, Reinholt, Jenssen (bb0390) 2012; 60 Matheus de, Tannus, Cobas, Palma, Negrato, de Gomes (bb0280) 2013; 2013 Bonneh-Barkay, Wiley (bb0165) 2009; 19 Dong, Qin, Xu, Wang (bb0505) 2011; 49 Susic, Varagic, Ahn, Frohlich (bb0595) 2004; 19 Scindia, Deshmukh, Bagavant (bb0365) 2010; 62 Pozzi, Zent, Chetyrkin, Borza, Bulus, Chuang, Chen, Hudson, Voziyan (bb0420) 2009; 20 Rolewska, Al-Robaiy, Navarrete Santos, Simm, Silber, Bartling (bb0235) 2013; 48 Genovese, Manresa, Leeming, Karsdal, Boor (bb0370) 2014; 7 Satheesan, Figarola, Dabbs, Rahbar, Ermel (bb0585) 2014; 171 Burgstaller, Oehrle, Gerckens, White, Schiller, Eickelberg (bb0220) 2017; 50 Kim, Dalal, Young, Legato, Weisfeldt, D’Armiento (bb0275) 2000; 106 Dwyer, Greco, Umanath, Packham, Fox, Peterson, Broome, Greene, Sika, Lewis (bb0575) 2015; 129 Buetler, Leclerc, Baumeyer, Latado, Newell, Adolfsson, Parisod, Richoz, Maurer, Foata, Piguet, Junod, Heizmann, Delatour (bb0020) 2008; 52 Anderson, Kim, Tsilibary (bb0410) 1994; 46 Voziyan, Brown, Chetyrkin, Hudson (bb0055) 2014; 52 Chang, Liang, Tsai, Wu, Hsu (bb0560) 2009; 157 Simm (10.1016/j.bbagen.2019.08.004_bb0290) 2013; 92 LeWinter (10.1016/j.bbagen.2019.08.004_bb0330) 2017; 5 Deluyker (10.1016/j.bbagen.2019.08.004_bb0335) 2016; 210 Bellmunt (10.1016/j.bbagen.2019.08.004_bb0230) 1995; 173 Alikhani (10.1016/j.bbagen.2019.08.004_bb0495) 2007; 40 Urios (10.1016/j.bbagen.2019.08.004_bb0635) 2007; 46 Trackman (10.1016/j.bbagen.2019.08.004_bb0485) 2016; 52–54 Scindia (10.1016/j.bbagen.2019.08.004_bb0365) 2010; 62 Aronson (10.1016/j.bbagen.2019.08.004_bb0355) 2003; 21 Charonis (10.1016/j.bbagen.2019.08.004_bb0075) 1992; 41 Ehrlich (10.1016/j.bbagen.2019.08.004_bb0465) 2010; 92 Kwok (10.1016/j.bbagen.2019.08.004_bb0155) 2011; 71 Satheesan (10.1016/j.bbagen.2019.08.004_bb0585) 2014; 171 Kim (10.1016/j.bbagen.2019.08.004_bb0275) 2000; 106 Hartog (10.1016/j.bbagen.2019.08.004_bb0305) 2007; 9 Eble (10.1016/j.bbagen.2019.08.004_bb0095) 2009; 15 Anderson (10.1016/j.bbagen.2019.08.004_bb0410) 1994; 46 Makino (10.1016/j.bbagen.2019.08.004_bb0400) 2000; 77 Shapiro (10.1016/j.bbagen.2019.08.004_bb0045) 1991; 87 Chandra (10.1016/j.bbagen.2019.08.004_bb0610) 2009; 29 Willemsen (10.1016/j.bbagen.2019.08.004_bb0285) 2012; 17 Yang (10.1016/j.bbagen.2019.08.004_bb0500) 2016; 99 Lo (10.1016/j.bbagen.2019.08.004_bb0415) 1994; 269 Chang (10.1016/j.bbagen.2019.08.004_bb0560) 2009; 157 Duran-Jimenez (10.1016/j.bbagen.2019.08.004_bb0035) 2009; 58 Mooney (10.1016/j.bbagen.2019.08.004_bb0405) 1999; 155 Rienks (10.1016/j.bbagen.2019.08.004_bb0270) 2014; 114 Duca (10.1016/j.bbagen.2019.08.004_bb0250) 2016; 110 McLennan (10.1016/j.bbagen.2019.08.004_bb0435) 2002; 51 Vlassara (10.1016/j.bbagen.2019.08.004_bb0120) 1996; 28 Panwar (10.1016/j.bbagen.2019.08.004_bb0510) 2018; 65 Abar (10.1016/j.bbagen.2019.08.004_bb0555) 2018; 7 Rascher (10.1016/j.bbagen.2019.08.004_bb0200) 2002; 104 Genovese (10.1016/j.bbagen.2019.08.004_bb0370) 2014; 7 Faner (10.1016/j.bbagen.2019.08.004_bb0225) 2012; 186 Perez Gutierrez (10.1016/j.bbagen.2019.08.004_bb0630) 2014; 52 Fujimoto (10.1016/j.bbagen.2019.08.004_bb0600) 2013; 6 Vlassara (10.1016/j.bbagen.2019.08.004_bb0380) 1994; 91 Katayama (10.1016/j.bbagen.2019.08.004_bb0470) 1996; 11 Jones (10.1016/j.bbagen.2019.08.004_bb0245) 2018; 7 Hollenbach (10.1016/j.bbagen.2019.08.004_bb0590) 2003; 243 Sims (10.1016/j.bbagen.2019.08.004_bb0110) 1996; 39 Buetler (10.1016/j.bbagen.2019.08.004_bb0020) 2008; 52 Nakamura (10.1016/j.bbagen.2019.08.004_bb0545) 1997; 46 Frantz (10.1016/j.bbagen.2019.08.004_bb0050) 2010; 123 Matheus de (10.1016/j.bbagen.2019.08.004_bb0280) 2013; 2013 Ural (10.1016/j.bbagen.2019.08.004_bb0460) 2015; 26 Baeten (10.1016/j.bbagen.2019.08.004_bb0195) 2011; 71 Makino (10.1016/j.bbagen.2019.08.004_bb0395) 1995; 48 Thornalley (10.1016/j.bbagen.2019.08.004_bb0005) 1999; 344 McCarthy (10.1016/j.bbagen.2019.08.004_bb0475) 2001; 2 Bohlender (10.1016/j.bbagen.2019.08.004_bb0385) 2005; 289 Miner (10.1016/j.bbagen.2019.08.004_bb0360) 2012; 318 Luo (10.1016/j.bbagen.2019.08.004_bb0180) 2002; 249 Rao (10.1016/j.bbagen.2019.08.004_bb0530) 1988; 151 Rolewska (10.1016/j.bbagen.2019.08.004_bb0235) 2013; 48 Arias (10.1016/j.bbagen.2019.08.004_bb0445) 2018; 13 Xu (10.1016/j.bbagen.2019.08.004_bb0085) 2014; 1842 Blackburn (10.1016/j.bbagen.2019.08.004_bb0345) 2017; 112 Kesavan (10.1016/j.bbagen.2019.08.004_bb0535) 2013; 3 Valencia (10.1016/j.bbagen.2019.08.004_bb0025) 2004; 47 Kulkarni (10.1016/j.bbagen.2019.08.004_bb0030) 2013; 7 Krantz (10.1016/j.bbagen.2019.08.004_bb0130) 1988; 91 Ramkissoon (10.1016/j.bbagen.2019.08.004_bb0615) 2013; 6 Watkins (10.1016/j.bbagen.2019.08.004_bb0175) 1995; 88 Susic (10.1016/j.bbagen.2019.08.004_bb0595) 2004; 19 Brownlee (10.1016/j.bbagen.2019.08.004_bb0015) 2001; 414 Wang (10.1016/j.bbagen.2019.08.004_bb0440) 2011; 5 Herrmann (10.1016/j.bbagen.2019.08.004_bb0315) 2003; 284 Rauch (10.1016/j.bbagen.2019.08.004_bb0160) 2007; 35 Bansode (10.1016/j.bbagen.2019.08.004_bb0010) 2013; 12 Correa-Giannella (10.1016/j.bbagen.2019.08.004_bb0135) 2012; 4 Engelhardt (10.1016/j.bbagen.2019.08.004_bb0210) 2011; 31 Nagai (10.1016/j.bbagen.2019.08.004_bb0580) 2012; 61 Lau (10.1016/j.bbagen.2019.08.004_bb0150) 2013; 14 Hipkiss (10.1016/j.bbagen.2019.08.004_bb0525) 1994; 22 Pozzi (10.1016/j.bbagen.2019.08.004_bb0420) 2009; 20 Ruggiero-Lopez (10.1016/j.bbagen.2019.08.004_bb0540) 1999; 58 Di Petta (10.1016/j.bbagen.2019.08.004_bb0255) 2011; 92 Dobler (10.1016/j.bbagen.2019.08.004_bb0350) 2006; 55 Endemann (10.1016/j.bbagen.2019.08.004_bb0430) 2004; 15 Bodiga (10.1016/j.bbagen.2019.08.004_bb0300) 2014; 19 Xian (10.1016/j.bbagen.2019.08.004_bb0070) 2010; 339 Tang (10.1016/j.bbagen.2019.08.004_bb0455) 2007; 40 Bonneh-Barkay (10.1016/j.bbagen.2019.08.004_bb0165) 2009; 19 Pedchenko (10.1016/j.bbagen.2019.08.004_bb0425) 2005; 54 Thomas (10.1016/j.bbagen.2019.08.004_bb0515) 2017; 525 Federoff (10.1016/j.bbagen.2019.08.004_bb0190) 1993; 42 Thornalley (10.1016/j.bbagen.2019.08.004_bb0375) 2009; 22 Chang (10.1016/j.bbagen.2019.08.004_bb0265) 2016; 10 Burgstaller (10.1016/j.bbagen.2019.08.004_bb0220) 2017; 50 Kolset (10.1016/j.bbagen.2019.08.004_bb0390) 2012; 60 Voziyan (10.1016/j.bbagen.2019.08.004_bb0055) 2014; 52 Powell (10.1016/j.bbagen.2019.08.004_bb0090) 1992; 97 Dong (10.1016/j.bbagen.2019.08.004_bb0505) 2011; 49 Bolton (10.1016/j.bbagen.2019.08.004_bb0565) 2004; 24 Zhang (10.1016/j.bbagen.2019.08.004_bb0080) 2009; 30 McCarthy (10.1016/j.bbagen.2019.08.004_bb0480) 2004; 36 Czuriga (10.1016/j.bbagen.2019.08.004_bb0325) 2012; 13 Verzijl (10.1016/j.bbagen.2019.08.004_bb0040) 2000; 275 Jacob (10.1016/j.bbagen.2019.08.004_bb0125) 2001; 159 Jagtap (10.1016/j.bbagen.2019.08.004_bb0625) 2010; 48 Harburger (10.1016/j.bbagen.2019.08.004_bb0060) 2009; 122 Li (10.1016/j.bbagen.2019.08.004_bb0170) 2012; 317 Janssen (10.1016/j.bbagen.2019.08.004_bb0260) 2018; 12 Reddy (10.1016/j.bbagen.2019.08.004_bb0105) 2004; 68 Dwyer (10.1016/j.bbagen.2019.08.004_bb0575) 2015; 129 Khosravi (10.1016/j.bbagen.2019.08.004_bb0490) 2014; 58 Hussain (10.1016/j.bbagen.2019.08.004_bb0205) 2016; 155 Gentili (10.1016/j.bbagen.2019.08.004_bb0450) 2009; 15 Williams (10.1016/j.bbagen.2019.08.004_bb0570) 2007; 27 Tiengo (10.1016/j.bbagen.2019.08.004_bb0240) 2008; 34 Mendez (10.1016/j.bbagen.2019.08.004_bb0520) 2004; 58 Ozturk (10.1016/j.bbagen.2019.08.004_bb0185) 2006; 112 Zieman (10.1016/j.bbagen.2019.08.004_bb0295) 2004; 10 Shapiro (10.1016/j.bbagen.2019.08.004_bb0320) 2008; 118 Rabbani (10.1016/j.bbagen.2019.08.004_bb0340) 2016; 130 Leitinger (10.1016/j.bbagen.2019.08.004_bb0065) 2007; 26 Joshi (10.1016/j.bbagen.2019.08.004_bb0605) 2009; 54 Voziyan (10.1016/j.bbagen.2019.08.004_bb0550) 2005; 1043 Avendano (10.1016/j.bbagen.2019.08.004_bb0310) 1999; 48 Sakata (10.1016/j.bbagen.2019.08.004_bb0115) 2003; 18 Perez Gutierrez (10.1016/j.bbagen.2019.08.004_bb0620) 2012; 2012 Dattani (10.1016/j.bbagen.2019.08.004_bb0145) 2018; 15 Koole (10.1016/j.bbagen.2019.08.004_bb0140) 2017; 65 Sell (10.1016/j.bbagen.2019.08.004_bb0100) 2012; 58 McDonald (10.1016/j.bbagen.2019.08.004_bb0215) 2009; 15 |
| References_xml | – volume: 21 start-page: 3 year: 2003 end-page: 12 ident: bb0355 article-title: Cross-linking of glycated collagen in the pathogenesis of arterial and myocardial stiffening of aging and diabetes publication-title: J. Hypertens. – volume: 20 start-page: 2119 year: 2009 end-page: 2125 ident: bb0420 article-title: Modification of collagen IV by glucose or methylglyoxal alters distinct mesangial cell functions publication-title: J. Am. Soc. Nephrol. – volume: 7 start-page: 155 year: 2013 end-page: 170 ident: bb0030 article-title: Glycated proteome: from reaction to intervention publication-title: Proteomics Clin. Appl. – volume: 58 start-page: 2893 year: 2009 end-page: 2903 ident: bb0035 article-title: Advanced glycation end products in extracellular matrix proteins contribute to the failure of sensory nerve regeneration in diabetes publication-title: Diabetes – volume: 186 start-page: 306 year: 2012 end-page: 313 ident: bb0225 article-title: Abnormal lung aging in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis publication-title: Am. J. Respir. Crit. Care Med. – volume: 51 start-page: 2612 year: 2002 end-page: 2618 ident: bb0435 article-title: Effects of mesangium glycation on matrix metalloproteinase activities: possible role in diabetic nephropathy publication-title: Diabetes – volume: 6 start-page: 1155 year: 2013 end-page: 1164 ident: bb0600 article-title: Cardiovascular effects of 1 year of alagebrium and endurance exercise training in healthy older individuals publication-title: Circ. Heart Fail. – volume: 22 start-page: 400 year: 2009 end-page: 404 ident: bb0375 article-title: Highlights and hotspots of protein glycation in end-stage renal disease publication-title: Semin. Dial. – volume: 58 start-page: 33 year: 2014 end-page: 41 ident: bb0490 article-title: Collagen advanced glycation inhibits its Discoidin Domain Receptor 2 (DDR2)-mediated induction of lysyl oxidase in osteoblasts publication-title: Bone – volume: 122 start-page: 159 year: 2009 end-page: 163 ident: bb0060 article-title: Integrin signalling at a glance publication-title: J. Cell Sci. – volume: 1842 start-page: 2106 year: 2014 end-page: 2119 ident: bb0085 article-title: Vascular wall extracellular matrix proteins and vascular diseases publication-title: Biochim. Biophys. Acta – volume: 155 start-page: 48 year: 2016 end-page: 54 ident: bb0205 article-title: Novel insights in the dysfunction of human blood-brain barrier after glycation publication-title: Mech. Ageing Dev. – volume: 29 start-page: 559 year: 2009 end-page: 575 ident: bb0610 article-title: Phase I clinical studies of the advanced glycation end-product (AGE)-breaker TRC4186: safety, tolerability and pharmacokinetics in healthy subjects publication-title: Clin. Drug Investig. – volume: 46 start-page: 1359 year: 1994 end-page: 1367 ident: bb0410 article-title: Effects of matrix glycation on mesangial cell adhesion, spreading and proliferation publication-title: Kidney Int. – volume: 71 start-page: 1018 year: 2011 end-page: 1039 ident: bb0195 article-title: Extracellular matrix and matrix receptors in blood-brain barrier formation and stroke publication-title: Dev. Neurobiol. – volume: 48 start-page: 2030 year: 2010 end-page: 2036 ident: bb0625 article-title: Antihyperglycemic activity and inhibition of advanced glycation end product formation by Cuminum cyminum in streptozotocin induced diabetic rats publication-title: Food Chem. Toxicol. – volume: 55 start-page: 1961 year: 2006 end-page: 1969 ident: bb0350 article-title: Increased dicarbonyl metabolism in endothelial cells in hyperglycemia induces anoikis and impairs angiogenesis by RGD and GFOGER motif modification publication-title: Diabetes – volume: 157 start-page: 1419 year: 2009 end-page: 1426 ident: bb0560 article-title: Prevention of arterial stiffening by pyridoxamine in diabetes is associated with inhibition of the pathogenic glycation on aortic collagen publication-title: Br. J. Pharmacol. – volume: 27 start-page: 605 year: 2007 end-page: 614 ident: bb0570 article-title: Effects of pyridoxamine in combined phase 2 studies of patients with type 1 and type 2 diabetes and overt nephropathy publication-title: Am. J. Nephrol. – volume: 15 start-page: 1983 year: 2004 end-page: 1992 ident: bb0430 article-title: Endothelial dysfunction publication-title: J. Am. Soc. Nephrol. – volume: 249 start-page: 424 year: 2002 end-page: 431 ident: bb0180 article-title: Effects of nonenzymatic glycosylation of extracellular matrix components on cell survival and sensory neurite extension in cell culture publication-title: J. Neurol. – volume: 99 start-page: 373 year: 2016 end-page: 383 ident: bb0500 article-title: Bone formation is affected by matrix advanced glycation end products (AGEs) in vivo publication-title: Calcif. Tissue Int. – volume: 15 start-page: 1509 year: 2009 end-page: 1520 ident: bb0215 article-title: Advanced glycation of the Arg-Gly-Asp (RGD) tripeptide motif modulates retinal microvascular endothelial cell dysfunction publication-title: Mol. Vis. – volume: 40 start-page: 345 year: 2007 end-page: 353 ident: bb0495 article-title: Advanced glycation end products stimulate osteoblast apoptosis via the MAP kinase and cytosolic apoptotic pathways publication-title: Bone – volume: 112 start-page: 627 year: 2006 end-page: 632 ident: bb0185 article-title: The effect of non-enzymatic glycation of extracellular matrix proteins on axonal regeneration in vitro publication-title: Acta Neuropathol. – volume: 54 start-page: 2952 year: 2005 end-page: 2960 ident: bb0425 article-title: Mechanism of perturbation of integrin-mediated cell-matrix interactions by reactive carbonyl compounds and its implication for pathogenesis of diabetic nephropathy publication-title: Diabetes – volume: 24 start-page: 32 year: 2004 end-page: 40 ident: bb0565 article-title: Randomized trial of an inhibitor of formation of advanced glycation end products in diabetic nephropathy publication-title: Am. J. Nephrol. – volume: 26 start-page: 146 year: 2007 end-page: 155 ident: bb0065 article-title: Mammalian collagen receptors publication-title: Matrix Biol. – volume: 58 start-page: 1765 year: 1999 end-page: 1773 ident: bb0540 article-title: Reaction of metformin with dicarbonyl compounds. Possible implication in the inhibition of advanced glycation end product formation publication-title: Biochem. Pharmacol. – volume: 123 start-page: 4195 year: 2010 end-page: 4200 ident: bb0050 article-title: The extracellular matrix at a glance publication-title: J. Cell Sci. – volume: 97 start-page: 201 year: 1992 end-page: 208 ident: bb0090 article-title: On the accumulation of publication-title: Atherosclerosis – volume: 7 year: 2018 ident: bb0245 article-title: Nanoscale dysregulation of collagen structure-function disrupts mechano-homeostasis and mediates pulmonary fibrosis publication-title: Elife – volume: 58 start-page: 227 year: 2012 end-page: 237 ident: bb0100 article-title: Molecular basis of arterial stiffening: role of glycation - a mini-review publication-title: Gerontology – volume: 269 start-page: 32299 year: 1994 end-page: 32305 ident: bb0415 article-title: Binding and modification of proteins by methylglyoxal under physiological conditions. A kinetic and mechanistic study with N alpha-acetylarginine, N alpha-acetylcysteine, and N alpha-acetyllysine, and bovine serum albumin publication-title: J. Biol. Chem. – volume: 5 start-page: 193 year: 2011 end-page: 200 ident: bb0440 article-title: CCN-2 is up-regulated by and mediates effects of matrix bound advanced glycated end-products in human renal mesangial cells publication-title: J. Cell Commun. Signal. – volume: 54 start-page: 72 year: 2009 end-page: 81 ident: bb0605 article-title: TRC4186, a novel AGE-breaker, improves diabetic cardiomyopathy and nephropathy in Ob-ZSF1 model of type 2 diabetes publication-title: J. Cardiovasc. Pharmacol. – volume: 15 start-page: 1334 year: 2009 end-page: 1348 ident: bb0450 article-title: Cartilage and bone extracellular matrix publication-title: Curr. Pharm. Des. – volume: 61 start-page: 549 year: 2012 end-page: 559 ident: bb0580 article-title: Chelation: a fundamental mechanism of action of AGE inhibitors, AGE breakers, and other inhibitors of diabetes complications publication-title: Diabetes – volume: 15 start-page: 367 year: 2018 end-page: 374 ident: bb0145 article-title: Diabetes mellitus and abdominal aortic aneurysms: a review of the mechanisms underlying the negative relationship publication-title: Diab. Vasc. Dis. Res. – volume: 62 start-page: 1337 year: 2010 end-page: 1343 ident: bb0365 article-title: Mesangial pathology in glomerular disease: targets for therapeutic intervention publication-title: Adv. Drug Deliv. Rev. – volume: 19 start-page: 336 year: 2004 end-page: 340 ident: bb0595 article-title: Crosslink breakers: a new approach to cardiovascular therapy publication-title: Curr. Opin. Cardiol. – volume: 68 start-page: 132 year: 2004 end-page: 142 ident: bb0105 article-title: AGE-related cross-linking of collagen is associated with aortic wall matrix stiffness in the pathogenesis of drug-induced diabetes in rats publication-title: Microvasc. Res. – volume: 243 start-page: 73 year: 2003 end-page: 80 ident: bb0590 article-title: Cleavage of in vitro and in vivo formed lens protein cross-links by a novel cross-link breaker publication-title: Mol. Cell. Biochem. – volume: 6 start-page: 561 year: 2013 end-page: 569 ident: bb0615 article-title: Antioxidant and anti-glycation activities correlates with phenolic composition of tropical medicinal herbs publication-title: Asian Pac J Trop Med – volume: 110 start-page: 298 year: 2016 end-page: 308 ident: bb0250 article-title: Matrix ageing and vascular impacts: focus on elastin fragmentation publication-title: Cardiovasc. Res. – volume: 13 start-page: 2532 year: 2012 end-page: 2538 ident: bb0325 article-title: Cellular mechanisms for diastolic dysfunction in the human heart publication-title: Curr. Pharm. Biotechnol. – volume: 9 start-page: 1146 year: 2007 end-page: 1155 ident: bb0305 article-title: Advanced glycation end-products (AGEs) and heart failure: pathophysiology and clinical implications publication-title: Eur. J. Heart Fail. – volume: 275 start-page: 39027 year: 2000 end-page: 39031 ident: bb0040 article-title: Effect of collagen turnover on the accumulation of advanced glycation end products publication-title: J. Biol. Chem. – volume: 28 start-page: 419 year: 1996 end-page: 426 ident: bb0120 article-title: Advanced glycation end-products and atherosclerosis publication-title: Ann. Med. – volume: 40 start-page: 1144 year: 2007 end-page: 1151 ident: bb0455 article-title: Effects of non-enzymatic glycation on cancellous bone fragility publication-title: Bone – volume: 42 start-page: 509 year: 1993 end-page: 513 ident: bb0190 article-title: Nonenzymatic glycosylation of laminin and the laminin peptide CIKVAVS inhibits neurite outgrowth publication-title: Diabetes – volume: 91 start-page: 11704 year: 1994 end-page: 11708 ident: bb0380 article-title: Advanced glycation end products induce glomerular sclerosis and albuminuria in normal rats publication-title: Proc. Natl. Acad. Sci. U. S. A. – volume: 129 start-page: 22 year: 2015 end-page: 28 ident: bb0575 article-title: Pyridoxamine dihydrochloride in diabetic nephropathy (PIONEER-CSG-17): lessons learned from a pilot study publication-title: Nephron – volume: 5 year: 2017 ident: bb0330 article-title: Abundance, localization, and functional correlates of the advanced glycation end-product carboxymethyl lysine in human myocardium publication-title: Phys. Rep. – volume: 114 start-page: 872 year: 2014 end-page: 888 ident: bb0270 article-title: Myocardial extracellular matrix: an ever-changing and diverse entity publication-title: Circ. Res. – volume: 151 start-page: 991 year: 1988 end-page: 996 ident: bb0530 article-title: Aspirin prevents the nonenzymatic glycosylation and carbamylation of the human eye lens crystallins in vitro publication-title: Biochem. Biophys. Res. Commun. – volume: 18 start-page: 1601 year: 2003 end-page: 1609 ident: bb0115 article-title: Modification of elastin by pentosidine is associated with the calcification of aortic media in patients with end-stage renal disease publication-title: Nephrol. Dial. Transplant. – volume: 92 start-page: 542 year: 2010 end-page: 551 ident: bb0465 article-title: Carboxymethylation of the fibrillar collagen with respect to formation of hydroxyapatite publication-title: J Biomed. Mater. Res. B Appl. Biomater. – volume: 525 start-page: 46 year: 2017 end-page: 53 ident: bb0515 article-title: Identification and characterization of glycation adducts on osteocalcin publication-title: Anal. Biochem. – volume: 1043 start-page: 807 year: 2005 end-page: 816 ident: bb0550 article-title: Pyridoxamine: the many virtues of a maillard reaction inhibitor publication-title: Ann. N. Y. Acad. Sci. – volume: 52 start-page: 1435 year: 2014 end-page: 1444 ident: bb0630 article-title: Beneficial effect of publication-title: Pharm. Biol. – volume: 50 year: 2017 ident: bb0220 article-title: The instructive extracellular matrix of the lung: basic composition and alterations in chronic lung disease publication-title: Eur. Respir. J. – volume: 112 start-page: 57 year: 2017 ident: bb0345 article-title: Methylglyoxal-derived advanced glycation end products contribute to negative cardiac remodeling and dysfunction post-myocardial infarction publication-title: Basic Res. Cardiol. – volume: 19 start-page: 49 year: 2014 end-page: 63 ident: bb0300 article-title: Advanced glycation end products: role in pathology of diabetic cardiomyopathy publication-title: Heart Fail. Rev. – volume: 60 start-page: 976 year: 2012 end-page: 986 ident: bb0390 article-title: Diabetic nephropathy and extracellular matrix publication-title: J. Histochem. Cytochem. – volume: 4 start-page: 19 year: 2012 ident: bb0135 article-title: Fibronectin glycation increases IGF-I induced proliferation of human aortic smooth muscle cells publication-title: Diabetol. Metab. Syndr. – volume: 2 start-page: 16 year: 2001 ident: bb0475 article-title: Non-enzymatic glycosylation of a type I collagen matrix: effects on osteoblastic development and oxidative stress publication-title: BMC Cell Biol. – volume: 173 start-page: 177 year: 1995 end-page: 185 ident: bb0230 article-title: Age-related fluorescence in rat lung collagen publication-title: Lung – volume: 7 start-page: 4 year: 2014 ident: bb0370 article-title: The extracellular matrix in the kidney: a source of novel non-invasive biomarkers of kidney fibrosis? publication-title: Fibrogenesis Tissue Repair – volume: 30 start-page: 4021 year: 2009 end-page: 4028 ident: bb0080 article-title: Tissue-specific extracellular matrix coatings for the promotion of cell proliferation and maintenance of cell phenotype publication-title: Biomaterials – volume: 171 start-page: 3103 year: 2014 end-page: 3114 ident: bb0585 article-title: Effects of a new advanced glycation inhibitor, LR-90, on mitigating arterial stiffening and improving arterial elasticity and compliance in a diabetic rat model: aortic impedance analysis publication-title: Br. J. Pharmacol. – volume: 414 start-page: 813 year: 2001 end-page: 820 ident: bb0015 article-title: Biochemistry and molecular cell biology of diabetic complications publication-title: Nature – volume: 317 start-page: 1 year: 2012 end-page: 5 ident: bb0170 article-title: Advanced glycation end products and neurodegenerative diseases: mechanisms and perspective publication-title: J. Neurol. Sci. – volume: 12 start-page: 228 year: 2013 end-page: 236 ident: bb0010 article-title: Proteomic analysis of protease resistant proteins in the diabetic rat kidney publication-title: Mol. Cell. Proteomics – volume: 210 start-page: 100 year: 2016 end-page: 108 ident: bb0335 article-title: Cross-linking versus RAGE: how do high molecular weight advanced glycation products induce cardiac dysfunction? publication-title: Int. J. Cardiol. – volume: 22 start-page: 399S year: 1994 ident: bb0525 article-title: Carnosine protects proteins against in vitro glycation and cross-linking publication-title: Biochem. Soc. Trans. – volume: 52 start-page: 370 year: 2008 end-page: 378 ident: bb0020 article-title: N(epsilon)-carboxymethyllysine-modified proteins are unable to bind to RAGE and activate an inflammatory response publication-title: Mol. Nutr. Food Res. – volume: 41 start-page: 49 year: 1992 end-page: 51 ident: bb0075 article-title: Structural and functional changes of laminin and type IV collagen after nonenzymatic glycation publication-title: Diabetes – volume: 344 start-page: 109 year: 1999 end-page: 116 ident: bb0005 article-title: Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose publication-title: Biochem. J. – volume: 46 start-page: 895 year: 1997 end-page: 899 ident: bb0545 article-title: Progression of nephropathy in spontaneous diabetic rats is prevented by OPB-9195, a novel inhibitor of advanced glycation publication-title: Diabetes – volume: 13 year: 2018 ident: bb0445 article-title: Bone remodeling: a tissue-level process emerging from cell-level molecular algorithms publication-title: PLoS One – volume: 2012 year: 2012 ident: bb0620 article-title: Inhibition of advanced glycation end-product formation by publication-title: Evid. Based Complement. Alternat. Med. – volume: 49 start-page: 174 year: 2011 end-page: 183 ident: bb0505 article-title: In situ accumulation of advanced glycation endproducts (AGEs) in bone matrix and its correlation with osteoclastic bone resorption publication-title: Bone – volume: 130 start-page: 1677 year: 2016 end-page: 1696 ident: bb0340 article-title: Methylglyoxal-induced dicarbonyl stress in aging and disease: first steps towards glyoxalase 1-based treatments publication-title: Clin. Sci. (Lond.) – volume: 15 start-page: 1385 year: 2009 end-page: 1400 ident: bb0095 article-title: The extracellular matrix of blood vessels publication-title: Curr. Pharm. Des. – volume: 65 start-page: 1493 year: 2017 end-page: 1503 ident: bb0140 article-title: A potential role for glycated cross-links in abdominal aortic aneurysm disease publication-title: J. Vasc. Surg. – volume: 39 start-page: 946 year: 1996 end-page: 951 ident: bb0110 article-title: The role of glycation cross-links in diabetic vascular stiffening publication-title: Diabetologia – volume: 19 start-page: 573 year: 2009 end-page: 585 ident: bb0165 article-title: Brain extracellular matrix in neurodegeneration publication-title: Brain Pathol. – volume: 7 start-page: 105 year: 2018 end-page: 110 ident: bb0555 article-title: The effect of aminoguanidine (AG) and pyridoxamine (PM) on ageing human cortical bone publication-title: Bone Joint Res. – volume: 106 start-page: 857 year: 2000 end-page: 866 ident: bb0275 article-title: Disruption of the myocardial extracellular matrix leads to cardiac dysfunction publication-title: J. Clin. Invest. – volume: 284 start-page: H1277 year: 2003 end-page: H1284 ident: bb0315 article-title: Glycated collagen cross-linking alters cardiac mechanics in volume-overload hypertrophy publication-title: Am. J. Physiol. Heart Circ. Physiol. – volume: 14 start-page: 722 year: 2013 end-page: 729 ident: bb0150 article-title: Pathophysiology of the brain extracellular matrix: a new target for remyelination publication-title: Nat. Rev. Neurosci. – volume: 48 start-page: 29 year: 2013 end-page: 37 ident: bb0235 article-title: Age-related expression, enzymatic solubility and modification with advanced glycation end-products of fibrillar collagens in mouse lung publication-title: Exp. Gerontol. – volume: 46 start-page: 139 year: 2007 end-page: 146 ident: bb0635 article-title: Flavonoids inhibit the formation of the cross-linking AGE pentosidine in collagen incubated with glucose, according to their structure publication-title: Eur. J. Nutr. – volume: 3 start-page: 2941 year: 2013 ident: bb0535 article-title: Proteome wide reduction in AGE modification in streptozotocin induced diabetic mice by hydralazine mediated transglycation publication-title: Sci. Rep. – volume: 88 start-page: 795 year: 1995 end-page: 804 ident: bb0175 article-title: Severe sensory-autonomic neuropathy and endocrinopathy in insulin-dependent diabetes publication-title: QJM – volume: 118 start-page: 1002 year: 2008 end-page: 1010 ident: bb0320 article-title: Advanced glycation end products accumulate in vascular smooth muscle and modify vascular but not ventricular properties in elderly hypertensive canines publication-title: Circulation – volume: 318 start-page: 973 year: 2012 end-page: 978 ident: bb0360 article-title: The glomerular basement membrane publication-title: Exp. Cell Res. – volume: 155 start-page: 599 year: 1999 end-page: 606 ident: bb0405 article-title: Type IV collagen and laminin regulate glomerular mesangial cell susceptibility to apoptosis via beta(1) integrin-mediated survival signals publication-title: Am. J. Pathol. – volume: 12 start-page: 349 year: 2018 end-page: 360 ident: bb0260 article-title: Inhalation therapy for repairing damaged elastin fibers and decelerating elastinolysis in chronic obstructive pulmonary disease publication-title: Expert Rev. Respir. Med. – volume: 10 start-page: 39 year: 2016 end-page: 50 ident: bb0265 article-title: Cardiac extracellular matrix proteomics: challenges, techniques, and clinical implications publication-title: Proteomics Clin. Appl. – volume: 71 start-page: 1073 year: 2011 end-page: 1089 ident: bb0155 article-title: Extracellular matrix and perineuronal nets in CNS repair publication-title: Dev. Neurobiol. – volume: 2013 year: 2013 ident: bb0280 article-title: Impact of diabetes on cardiovascular disease: an update publication-title: Int. J. Hypertens. – volume: 10 start-page: 141 year: 2004 end-page: 144 ident: bb0295 article-title: Advanced glycation end product cross-linking: pathophysiologic role and therapeutic target in cardiovascular disease publication-title: Congest. Heart Fail. – volume: 58 start-page: 598 year: 2004 end-page: 604 ident: bb0520 article-title: Inhibition of in vitro pyrraline formation by publication-title: Biomed. Pharmacother. – volume: 92 start-page: 392 year: 2011 end-page: 399 ident: bb0255 article-title: Insulin modulates inflammatory and repair responses to elastase-induced emphysema in diabetic rats publication-title: Int. J. Exp. Pathol. – volume: 31 start-page: 1969 year: 2011 end-page: 1971 ident: bb0210 article-title: Beta1-integrin/matrix interactions support blood-brain barrier integrity publication-title: J. Cereb. Blood Flow Metab. – volume: 48 start-page: 517 year: 1995 end-page: 526 ident: bb0395 article-title: Ultrastructure of nonenzymatically glycated mesangial matrix in diabetic nephropathy publication-title: Kidney Int. – volume: 26 start-page: 865 year: 2015 end-page: 873 ident: bb0460 article-title: Association between non-enzymatic glycation, resorption, and microdamage in human tibial cortices publication-title: Osteoporos. Int. – volume: 87 start-page: 1828 year: 1991 end-page: 1834 ident: bb0045 article-title: Marked longevity of human lung parenchymal elastic fibers deduced from prevalence of publication-title: J. Clin. Invest. – volume: 104 start-page: 85 year: 2002 end-page: 91 ident: bb0200 article-title: Extracellular matrix and the blood-brain barrier in glioblastoma multiforme: spatial segregation of tenascin and agrin publication-title: Acta Neuropathol. – volume: 48 start-page: 1443 year: 1999 end-page: 1447 ident: bb0310 article-title: Effects of glucose intolerance on myocardial function and collagen-linked glycation publication-title: Diabetes – volume: 159 start-page: 333 year: 2001 end-page: 341 ident: bb0125 article-title: Influence of non-enzymatically glycated collagen on monocyte-macrophage differentiation publication-title: Atherosclerosis – volume: 35 start-page: 656 year: 2007 end-page: 660 ident: bb0160 article-title: Brain matrix: structure, turnover and necessity publication-title: Biochem. Soc. Trans. – volume: 17 start-page: 221 year: 2012 end-page: 228 ident: bb0285 article-title: Advanced glycation end-products, a pathophysiological pathway in the cardiorenal syndrome publication-title: Heart Fail. Rev. – volume: 65 start-page: 30 year: 2018 end-page: 44 ident: bb0510 article-title: Aging-associated modifications of collagen affect its degradation by matrix metalloproteinases publication-title: Matrix Biol. – volume: 92 start-page: 248 year: 2013 end-page: 259 ident: bb0290 article-title: Protein glycation during aging and in cardiovascular disease publication-title: J. Proteome – volume: 339 start-page: 31 year: 2010 end-page: 46 ident: bb0070 article-title: Syndecans as receptors and organizers of the extracellular matrix publication-title: Cell Tissue Res. – volume: 11 start-page: 931 year: 1996 end-page: 937 ident: bb0470 article-title: Role of nonenzymatic glycosylation of type I collagen in diabetic osteopenia publication-title: J. Bone Miner. Res. – volume: 289 start-page: F645 year: 2005 end-page: F659 ident: bb0385 article-title: Advanced glycation end products and the kidney publication-title: Am. J. Physiol. Ren. Physiol. – volume: 52 start-page: 39 year: 2014 end-page: 45 ident: bb0055 article-title: Site-specific AGE modifications in the extracellular matrix: a role for glyoxal in protein damage in diabetes publication-title: Clin. Chem. Lab. Med. – volume: 91 start-page: 155 year: 1988 end-page: 160 ident: bb0130 article-title: Diminished adhesion of endothelial aortic cells on fibronectin and collagen layers after nonenzymatic glycation publication-title: Exp. Clin. Endocrinol. – volume: 52–54 start-page: 7 year: 2016 end-page: 18 ident: bb0485 article-title: Enzymatic and non-enzymatic functions of the lysyl oxidase family in bone publication-title: Matrix Biol. – volume: 36 start-page: 840 year: 2004 end-page: 848 ident: bb0480 article-title: Advanced glycation endproducts interefere with integrin-mediated osteoblastic attachment to a type-I collagen matrix publication-title: Int. J. Biochem. Cell Biol. – volume: 34 start-page: 447 year: 2008 end-page: 454 ident: bb0240 article-title: The metabolic syndrome, diabetes and lung dysfunction publication-title: Diabetes Metab. – volume: 77 start-page: S67 year: 2000 end-page: S75 ident: bb0400 article-title: Apoptosis and extracellular matrix-cell interactions in kidney disease publication-title: Kidney Int. Suppl. – volume: 47 start-page: 844 year: 2004 end-page: 852 ident: bb0025 article-title: Binding of receptor for advanced glycation end products (RAGE) ligands is not sufficient to induce inflammatory signals: lack of activity of endotoxin-free albumin-derived advanced glycation end products publication-title: Diabetologia – volume: 52–54 start-page: 7 year: 2016 ident: 10.1016/j.bbagen.2019.08.004_bb0485 article-title: Enzymatic and non-enzymatic functions of the lysyl oxidase family in bone publication-title: Matrix Biol. doi: 10.1016/j.matbio.2016.01.001 – volume: 317 start-page: 1 year: 2012 ident: 10.1016/j.bbagen.2019.08.004_bb0170 article-title: Advanced glycation end products and neurodegenerative diseases: mechanisms and perspective publication-title: J. Neurol. Sci. doi: 10.1016/j.jns.2012.02.018 – volume: 15 start-page: 1509 year: 2009 ident: 10.1016/j.bbagen.2019.08.004_bb0215 article-title: Advanced glycation of the Arg-Gly-Asp (RGD) tripeptide motif modulates retinal microvascular endothelial cell dysfunction publication-title: Mol. Vis. – volume: 46 start-page: 1359 year: 1994 ident: 10.1016/j.bbagen.2019.08.004_bb0410 article-title: Effects of matrix glycation on mesangial cell adhesion, spreading and proliferation publication-title: Kidney Int. doi: 10.1038/ki.1994.405 – volume: 42 start-page: 509 year: 1993 ident: 10.1016/j.bbagen.2019.08.004_bb0190 article-title: Nonenzymatic glycosylation of laminin and the laminin peptide CIKVAVS inhibits neurite outgrowth publication-title: Diabetes doi: 10.2337/diab.42.4.509 – volume: 19 start-page: 49 year: 2014 ident: 10.1016/j.bbagen.2019.08.004_bb0300 article-title: Advanced glycation end products: role in pathology of diabetic cardiomyopathy publication-title: Heart Fail. Rev. doi: 10.1007/s10741-013-9374-y – volume: 18 start-page: 1601 year: 2003 ident: 10.1016/j.bbagen.2019.08.004_bb0115 article-title: Modification of elastin by pentosidine is associated with the calcification of aortic media in patients with end-stage renal disease publication-title: Nephrol. Dial. Transplant. doi: 10.1093/ndt/gfg200 – volume: 36 start-page: 840 year: 2004 ident: 10.1016/j.bbagen.2019.08.004_bb0480 article-title: Advanced glycation endproducts interefere with integrin-mediated osteoblastic attachment to a type-I collagen matrix publication-title: Int. J. Biochem. Cell Biol. doi: 10.1016/j.biocel.2003.09.006 – volume: 112 start-page: 57 year: 2017 ident: 10.1016/j.bbagen.2019.08.004_bb0345 article-title: Methylglyoxal-derived advanced glycation end products contribute to negative cardiac remodeling and dysfunction post-myocardial infarction publication-title: Basic Res. Cardiol. doi: 10.1007/s00395-017-0646-x – volume: 40 start-page: 345 year: 2007 ident: 10.1016/j.bbagen.2019.08.004_bb0495 article-title: Advanced glycation end products stimulate osteoblast apoptosis via the MAP kinase and cytosolic apoptotic pathways publication-title: Bone doi: 10.1016/j.bone.2006.09.011 – volume: 91 start-page: 155 year: 1988 ident: 10.1016/j.bbagen.2019.08.004_bb0130 article-title: Diminished adhesion of endothelial aortic cells on fibronectin and collagen layers after nonenzymatic glycation publication-title: Exp. Clin. Endocrinol. doi: 10.1055/s-0029-1210738 – volume: 414 start-page: 813 year: 2001 ident: 10.1016/j.bbagen.2019.08.004_bb0015 article-title: Biochemistry and molecular cell biology of diabetic complications publication-title: Nature doi: 10.1038/414813a – volume: 27 start-page: 605 year: 2007 ident: 10.1016/j.bbagen.2019.08.004_bb0570 article-title: Effects of pyridoxamine in combined phase 2 studies of patients with type 1 and type 2 diabetes and overt nephropathy publication-title: Am. J. Nephrol. doi: 10.1159/000108104 – volume: 5 year: 2017 ident: 10.1016/j.bbagen.2019.08.004_bb0330 article-title: Abundance, localization, and functional correlates of the advanced glycation end-product carboxymethyl lysine in human myocardium publication-title: Phys. Rep. – volume: 87 start-page: 1828 year: 1991 ident: 10.1016/j.bbagen.2019.08.004_bb0045 article-title: Marked longevity of human lung parenchymal elastic fibers deduced from prevalence of d-aspartate and nuclear weapons-related radiocarbon publication-title: J. Clin. Invest. doi: 10.1172/JCI115204 – volume: 6 start-page: 1155 year: 2013 ident: 10.1016/j.bbagen.2019.08.004_bb0600 article-title: Cardiovascular effects of 1 year of alagebrium and endurance exercise training in healthy older individuals publication-title: Circ. Heart Fail. doi: 10.1161/CIRCHEARTFAILURE.113.000440 – volume: 17 start-page: 221 year: 2012 ident: 10.1016/j.bbagen.2019.08.004_bb0285 article-title: Advanced glycation end-products, a pathophysiological pathway in the cardiorenal syndrome publication-title: Heart Fail. Rev. doi: 10.1007/s10741-010-9225-z – volume: 14 start-page: 722 year: 2013 ident: 10.1016/j.bbagen.2019.08.004_bb0150 article-title: Pathophysiology of the brain extracellular matrix: a new target for remyelination publication-title: Nat. Rev. Neurosci. doi: 10.1038/nrn3550 – volume: 34 start-page: 447 year: 2008 ident: 10.1016/j.bbagen.2019.08.004_bb0240 article-title: The metabolic syndrome, diabetes and lung dysfunction publication-title: Diabetes Metab. doi: 10.1016/j.diabet.2008.08.001 – volume: 15 start-page: 1983 year: 2004 ident: 10.1016/j.bbagen.2019.08.004_bb0430 article-title: Endothelial dysfunction publication-title: J. Am. Soc. Nephrol. doi: 10.1097/01.ASN.0000132474.50966.DA – volume: 62 start-page: 1337 year: 2010 ident: 10.1016/j.bbagen.2019.08.004_bb0365 article-title: Mesangial pathology in glomerular disease: targets for therapeutic intervention publication-title: Adv. Drug Deliv. Rev. doi: 10.1016/j.addr.2010.08.011 – volume: 155 start-page: 48 year: 2016 ident: 10.1016/j.bbagen.2019.08.004_bb0205 article-title: Novel insights in the dysfunction of human blood-brain barrier after glycation publication-title: Mech. Ageing Dev. doi: 10.1016/j.mad.2016.03.004 – volume: 65 start-page: 30 year: 2018 ident: 10.1016/j.bbagen.2019.08.004_bb0510 article-title: Aging-associated modifications of collagen affect its degradation by matrix metalloproteinases publication-title: Matrix Biol. doi: 10.1016/j.matbio.2017.06.004 – volume: 88 start-page: 795 year: 1995 ident: 10.1016/j.bbagen.2019.08.004_bb0175 article-title: Severe sensory-autonomic neuropathy and endocrinopathy in insulin-dependent diabetes publication-title: QJM – volume: 30 start-page: 4021 year: 2009 ident: 10.1016/j.bbagen.2019.08.004_bb0080 article-title: Tissue-specific extracellular matrix coatings for the promotion of cell proliferation and maintenance of cell phenotype publication-title: Biomaterials doi: 10.1016/j.biomaterials.2009.04.005 – volume: 46 start-page: 139 year: 2007 ident: 10.1016/j.bbagen.2019.08.004_bb0635 article-title: Flavonoids inhibit the formation of the cross-linking AGE pentosidine in collagen incubated with glucose, according to their structure publication-title: Eur. J. Nutr. doi: 10.1007/s00394-007-0644-0 – volume: 13 start-page: 2532 year: 2012 ident: 10.1016/j.bbagen.2019.08.004_bb0325 article-title: Cellular mechanisms for diastolic dysfunction in the human heart publication-title: Curr. Pharm. Biotechnol. doi: 10.2174/1389201011208062532 – volume: 112 start-page: 627 year: 2006 ident: 10.1016/j.bbagen.2019.08.004_bb0185 article-title: The effect of non-enzymatic glycation of extracellular matrix proteins on axonal regeneration in vitro publication-title: Acta Neuropathol. doi: 10.1007/s00401-006-0124-2 – volume: 58 start-page: 33 year: 2014 ident: 10.1016/j.bbagen.2019.08.004_bb0490 article-title: Collagen advanced glycation inhibits its Discoidin Domain Receptor 2 (DDR2)-mediated induction of lysyl oxidase in osteoblasts publication-title: Bone doi: 10.1016/j.bone.2013.10.001 – volume: 10 start-page: 39 year: 2016 ident: 10.1016/j.bbagen.2019.08.004_bb0265 article-title: Cardiac extracellular matrix proteomics: challenges, techniques, and clinical implications publication-title: Proteomics Clin. Appl. doi: 10.1002/prca.201500030 – volume: 1842 start-page: 2106 year: 2014 ident: 10.1016/j.bbagen.2019.08.004_bb0085 article-title: Vascular wall extracellular matrix proteins and vascular diseases publication-title: Biochim. Biophys. Acta doi: 10.1016/j.bbadis.2014.07.008 – volume: 60 start-page: 976 year: 2012 ident: 10.1016/j.bbagen.2019.08.004_bb0390 article-title: Diabetic nephropathy and extracellular matrix publication-title: J. Histochem. Cytochem. doi: 10.1369/0022155412465073 – volume: 31 start-page: 1969 year: 2011 ident: 10.1016/j.bbagen.2019.08.004_bb0210 article-title: Beta1-integrin/matrix interactions support blood-brain barrier integrity publication-title: J. Cereb. Blood Flow Metab. doi: 10.1038/jcbfm.2011.98 – volume: 41 start-page: 49 issue: Suppl. 2 year: 1992 ident: 10.1016/j.bbagen.2019.08.004_bb0075 article-title: Structural and functional changes of laminin and type IV collagen after nonenzymatic glycation publication-title: Diabetes doi: 10.2337/diab.41.2.S49 – volume: 97 start-page: 201 year: 1992 ident: 10.1016/j.bbagen.2019.08.004_bb0090 article-title: On the accumulation of d-aspartate in elastin and other proteins of the ageing aorta publication-title: Atherosclerosis doi: 10.1016/0021-9150(92)90132-Z – volume: 68 start-page: 132 year: 2004 ident: 10.1016/j.bbagen.2019.08.004_bb0105 article-title: AGE-related cross-linking of collagen is associated with aortic wall matrix stiffness in the pathogenesis of drug-induced diabetes in rats publication-title: Microvasc. Res. doi: 10.1016/j.mvr.2004.04.002 – volume: 284 start-page: H1277 year: 2003 ident: 10.1016/j.bbagen.2019.08.004_bb0315 article-title: Glycated collagen cross-linking alters cardiac mechanics in volume-overload hypertrophy publication-title: Am. J. Physiol. Heart Circ. Physiol. doi: 10.1152/ajpheart.00168.2002 – volume: 55 start-page: 1961 year: 2006 ident: 10.1016/j.bbagen.2019.08.004_bb0350 article-title: Increased dicarbonyl metabolism in endothelial cells in hyperglycemia induces anoikis and impairs angiogenesis by RGD and GFOGER motif modification publication-title: Diabetes doi: 10.2337/db05-1634 – volume: 19 start-page: 336 year: 2004 ident: 10.1016/j.bbagen.2019.08.004_bb0595 article-title: Crosslink breakers: a new approach to cardiovascular therapy publication-title: Curr. Opin. Cardiol. doi: 10.1097/01.hco.0000127135.73849.4f – volume: 104 start-page: 85 year: 2002 ident: 10.1016/j.bbagen.2019.08.004_bb0200 article-title: Extracellular matrix and the blood-brain barrier in glioblastoma multiforme: spatial segregation of tenascin and agrin publication-title: Acta Neuropathol. doi: 10.1007/s00401-002-0524-x – volume: 22 start-page: 399S year: 1994 ident: 10.1016/j.bbagen.2019.08.004_bb0525 article-title: Carnosine protects proteins against in vitro glycation and cross-linking publication-title: Biochem. Soc. Trans. doi: 10.1042/bst022399s – volume: 52 start-page: 39 year: 2014 ident: 10.1016/j.bbagen.2019.08.004_bb0055 article-title: Site-specific AGE modifications in the extracellular matrix: a role for glyoxal in protein damage in diabetes publication-title: Clin. Chem. Lab. Med. doi: 10.1515/cclm-2012-0818 – volume: 5 start-page: 193 year: 2011 ident: 10.1016/j.bbagen.2019.08.004_bb0440 article-title: CCN-2 is up-regulated by and mediates effects of matrix bound advanced glycated end-products in human renal mesangial cells publication-title: J. Cell Commun. Signal. doi: 10.1007/s12079-011-0137-z – volume: 39 start-page: 946 year: 1996 ident: 10.1016/j.bbagen.2019.08.004_bb0110 article-title: The role of glycation cross-links in diabetic vascular stiffening publication-title: Diabetologia doi: 10.1007/BF00403914 – volume: 289 start-page: F645 year: 2005 ident: 10.1016/j.bbagen.2019.08.004_bb0385 article-title: Advanced glycation end products and the kidney publication-title: Am. J. Physiol. Ren. Physiol. doi: 10.1152/ajprenal.00398.2004 – volume: 171 start-page: 3103 year: 2014 ident: 10.1016/j.bbagen.2019.08.004_bb0585 article-title: Effects of a new advanced glycation inhibitor, LR-90, on mitigating arterial stiffening and improving arterial elasticity and compliance in a diabetic rat model: aortic impedance analysis publication-title: Br. J. Pharmacol. doi: 10.1111/bph.12656 – volume: 6 start-page: 561 year: 2013 ident: 10.1016/j.bbagen.2019.08.004_bb0615 article-title: Antioxidant and anti-glycation activities correlates with phenolic composition of tropical medicinal herbs publication-title: Asian Pac J Trop Med doi: 10.1016/S1995-7645(13)60097-8 – volume: 186 start-page: 306 year: 2012 ident: 10.1016/j.bbagen.2019.08.004_bb0225 article-title: Abnormal lung aging in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis publication-title: Am. J. Respir. Crit. Care Med. doi: 10.1164/rccm.201202-0282PP – volume: 61 start-page: 549 year: 2012 ident: 10.1016/j.bbagen.2019.08.004_bb0580 article-title: Chelation: a fundamental mechanism of action of AGE inhibitors, AGE breakers, and other inhibitors of diabetes complications publication-title: Diabetes doi: 10.2337/db11-1120 – volume: 58 start-page: 2893 year: 2009 ident: 10.1016/j.bbagen.2019.08.004_bb0035 article-title: Advanced glycation end products in extracellular matrix proteins contribute to the failure of sensory nerve regeneration in diabetes publication-title: Diabetes doi: 10.2337/db09-0320 – volume: 35 start-page: 656 year: 2007 ident: 10.1016/j.bbagen.2019.08.004_bb0160 article-title: Brain matrix: structure, turnover and necessity publication-title: Biochem. Soc. Trans. doi: 10.1042/BST0350656 – volume: 155 start-page: 599 year: 1999 ident: 10.1016/j.bbagen.2019.08.004_bb0405 article-title: Type IV collagen and laminin regulate glomerular mesangial cell susceptibility to apoptosis via beta(1) integrin-mediated survival signals publication-title: Am. J. Pathol. doi: 10.1016/S0002-9440(10)65155-3 – volume: 9 start-page: 1146 year: 2007 ident: 10.1016/j.bbagen.2019.08.004_bb0305 article-title: Advanced glycation end-products (AGEs) and heart failure: pathophysiology and clinical implications publication-title: Eur. J. Heart Fail. doi: 10.1016/j.ejheart.2007.09.009 – volume: 344 start-page: 109 issue: Pt 1 year: 1999 ident: 10.1016/j.bbagen.2019.08.004_bb0005 article-title: Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose publication-title: Biochem. J. doi: 10.1042/bj3440109 – volume: 1043 start-page: 807 year: 2005 ident: 10.1016/j.bbagen.2019.08.004_bb0550 article-title: Pyridoxamine: the many virtues of a maillard reaction inhibitor publication-title: Ann. N. Y. Acad. Sci. doi: 10.1196/annals.1333.093 – volume: 525 start-page: 46 year: 2017 ident: 10.1016/j.bbagen.2019.08.004_bb0515 article-title: Identification and characterization of glycation adducts on osteocalcin publication-title: Anal. Biochem. doi: 10.1016/j.ab.2017.02.011 – volume: 49 start-page: 174 year: 2011 ident: 10.1016/j.bbagen.2019.08.004_bb0505 article-title: In situ accumulation of advanced glycation endproducts (AGEs) in bone matrix and its correlation with osteoclastic bone resorption publication-title: Bone doi: 10.1016/j.bone.2011.04.009 – volume: 65 start-page: 1493 year: 2017 ident: 10.1016/j.bbagen.2019.08.004_bb0140 article-title: A potential role for glycated cross-links in abdominal aortic aneurysm disease publication-title: J. Vasc. Surg. doi: 10.1016/j.jvs.2016.04.028 – volume: 243 start-page: 73 year: 2003 ident: 10.1016/j.bbagen.2019.08.004_bb0590 article-title: Cleavage of in vitro and in vivo formed lens protein cross-links by a novel cross-link breaker publication-title: Mol. Cell. Biochem. doi: 10.1023/A:1021660105893 – volume: 10 start-page: 141 year: 2004 ident: 10.1016/j.bbagen.2019.08.004_bb0295 article-title: Advanced glycation end product cross-linking: pathophysiologic role and therapeutic target in cardiovascular disease publication-title: Congest. Heart Fail. doi: 10.1111/j.1527-5299.2004.03223.x – volume: 2012 year: 2012 ident: 10.1016/j.bbagen.2019.08.004_bb0620 article-title: Inhibition of advanced glycation end-product formation by Origanum majorana L. In vitro and in streptozotocin-induced diabetic rats publication-title: Evid. Based Complement. Alternat. Med. doi: 10.1155/2012/598638 – volume: 110 start-page: 298 year: 2016 ident: 10.1016/j.bbagen.2019.08.004_bb0250 article-title: Matrix ageing and vascular impacts: focus on elastin fragmentation publication-title: Cardiovasc. Res. doi: 10.1093/cvr/cvw061 – volume: 122 start-page: 159 year: 2009 ident: 10.1016/j.bbagen.2019.08.004_bb0060 article-title: Integrin signalling at a glance publication-title: J. Cell Sci. doi: 10.1242/jcs.018093 – volume: 15 start-page: 367 year: 2018 ident: 10.1016/j.bbagen.2019.08.004_bb0145 article-title: Diabetes mellitus and abdominal aortic aneurysms: a review of the mechanisms underlying the negative relationship publication-title: Diab. Vasc. Dis. Res. doi: 10.1177/1479164118780799 – volume: 58 start-page: 598 year: 2004 ident: 10.1016/j.bbagen.2019.08.004_bb0520 article-title: Inhibition of in vitro pyrraline formation by l-arginine and polyamines publication-title: Biomed. Pharmacother. doi: 10.1016/j.biopha.2004.09.004 – volume: 54 start-page: 2952 year: 2005 ident: 10.1016/j.bbagen.2019.08.004_bb0425 article-title: Mechanism of perturbation of integrin-mediated cell-matrix interactions by reactive carbonyl compounds and its implication for pathogenesis of diabetic nephropathy publication-title: Diabetes doi: 10.2337/diabetes.54.10.2952 – volume: 15 start-page: 1334 year: 2009 ident: 10.1016/j.bbagen.2019.08.004_bb0450 article-title: Cartilage and bone extracellular matrix publication-title: Curr. Pharm. Des. doi: 10.2174/138161209787846739 – volume: 92 start-page: 542 year: 2010 ident: 10.1016/j.bbagen.2019.08.004_bb0465 article-title: Carboxymethylation of the fibrillar collagen with respect to formation of hydroxyapatite publication-title: J Biomed. Mater. Res. B Appl. Biomater. doi: 10.1002/jbm.b.31551 – volume: 2013 year: 2013 ident: 10.1016/j.bbagen.2019.08.004_bb0280 article-title: Impact of diabetes on cardiovascular disease: an update publication-title: Int. J. Hypertens. doi: 10.1155/2013/653789 – volume: 48 start-page: 2030 year: 2010 ident: 10.1016/j.bbagen.2019.08.004_bb0625 article-title: Antihyperglycemic activity and inhibition of advanced glycation end product formation by Cuminum cyminum in streptozotocin induced diabetic rats publication-title: Food Chem. Toxicol. doi: 10.1016/j.fct.2010.04.048 – volume: 52 start-page: 370 year: 2008 ident: 10.1016/j.bbagen.2019.08.004_bb0020 article-title: N(epsilon)-carboxymethyllysine-modified proteins are unable to bind to RAGE and activate an inflammatory response publication-title: Mol. Nutr. Food Res. doi: 10.1002/mnfr.200700101 – volume: 7 start-page: 155 year: 2013 ident: 10.1016/j.bbagen.2019.08.004_bb0030 article-title: Glycated proteome: from reaction to intervention publication-title: Proteomics Clin. Appl. doi: 10.1002/prca.201200101 – volume: 58 start-page: 1765 year: 1999 ident: 10.1016/j.bbagen.2019.08.004_bb0540 article-title: Reaction of metformin with dicarbonyl compounds. Possible implication in the inhibition of advanced glycation end product formation publication-title: Biochem. Pharmacol. doi: 10.1016/S0006-2952(99)00263-4 – volume: 28 start-page: 419 year: 1996 ident: 10.1016/j.bbagen.2019.08.004_bb0120 article-title: Advanced glycation end-products and atherosclerosis publication-title: Ann. Med. doi: 10.3109/07853899608999102 – volume: 48 start-page: 517 year: 1995 ident: 10.1016/j.bbagen.2019.08.004_bb0395 article-title: Ultrastructure of nonenzymatically glycated mesangial matrix in diabetic nephropathy publication-title: Kidney Int. doi: 10.1038/ki.1995.322 – volume: 20 start-page: 2119 year: 2009 ident: 10.1016/j.bbagen.2019.08.004_bb0420 article-title: Modification of collagen IV by glucose or methylglyoxal alters distinct mesangial cell functions publication-title: J. Am. Soc. Nephrol. doi: 10.1681/ASN.2008080900 – volume: 50 year: 2017 ident: 10.1016/j.bbagen.2019.08.004_bb0220 article-title: The instructive extracellular matrix of the lung: basic composition and alterations in chronic lung disease publication-title: Eur. Respir. J. doi: 10.1183/13993003.01805-2016 – volume: 77 start-page: S67 year: 2000 ident: 10.1016/j.bbagen.2019.08.004_bb0400 article-title: Apoptosis and extracellular matrix-cell interactions in kidney disease publication-title: Kidney Int. Suppl. doi: 10.1046/j.1523-1755.2000.07711.x – volume: 318 start-page: 973 year: 2012 ident: 10.1016/j.bbagen.2019.08.004_bb0360 article-title: The glomerular basement membrane publication-title: Exp. Cell Res. doi: 10.1016/j.yexcr.2012.02.031 – volume: 114 start-page: 872 year: 2014 ident: 10.1016/j.bbagen.2019.08.004_bb0270 article-title: Myocardial extracellular matrix: an ever-changing and diverse entity publication-title: Circ. Res. doi: 10.1161/CIRCRESAHA.114.302533 – volume: 47 start-page: 844 year: 2004 ident: 10.1016/j.bbagen.2019.08.004_bb0025 article-title: Binding of receptor for advanced glycation end products (RAGE) ligands is not sufficient to induce inflammatory signals: lack of activity of endotoxin-free albumin-derived advanced glycation end products publication-title: Diabetologia doi: 10.1007/s00125-004-1392-9 – volume: 130 start-page: 1677 year: 2016 ident: 10.1016/j.bbagen.2019.08.004_bb0340 article-title: Methylglyoxal-induced dicarbonyl stress in aging and disease: first steps towards glyoxalase 1-based treatments publication-title: Clin. Sci. (Lond.) doi: 10.1042/CS20160025 – volume: 48 start-page: 1443 year: 1999 ident: 10.1016/j.bbagen.2019.08.004_bb0310 article-title: Effects of glucose intolerance on myocardial function and collagen-linked glycation publication-title: Diabetes doi: 10.2337/diabetes.48.7.1443 – volume: 106 start-page: 857 year: 2000 ident: 10.1016/j.bbagen.2019.08.004_bb0275 article-title: Disruption of the myocardial extracellular matrix leads to cardiac dysfunction publication-title: J. Clin. Invest. doi: 10.1172/JCI8040 – volume: 11 start-page: 931 year: 1996 ident: 10.1016/j.bbagen.2019.08.004_bb0470 article-title: Role of nonenzymatic glycosylation of type I collagen in diabetic osteopenia publication-title: J. Bone Miner. Res. doi: 10.1002/jbmr.5650110709 – volume: 118 start-page: 1002 year: 2008 ident: 10.1016/j.bbagen.2019.08.004_bb0320 article-title: Advanced glycation end products accumulate in vascular smooth muscle and modify vascular but not ventricular properties in elderly hypertensive canines publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.108.777326 – volume: 71 start-page: 1073 year: 2011 ident: 10.1016/j.bbagen.2019.08.004_bb0155 article-title: Extracellular matrix and perineuronal nets in CNS repair publication-title: Dev. Neurobiol. doi: 10.1002/dneu.20974 – volume: 21 start-page: 3 year: 2003 ident: 10.1016/j.bbagen.2019.08.004_bb0355 article-title: Cross-linking of glycated collagen in the pathogenesis of arterial and myocardial stiffening of aging and diabetes publication-title: J. Hypertens. doi: 10.1097/00004872-200301000-00002 – volume: 71 start-page: 1018 year: 2011 ident: 10.1016/j.bbagen.2019.08.004_bb0195 article-title: Extracellular matrix and matrix receptors in blood-brain barrier formation and stroke publication-title: Dev. Neurobiol. doi: 10.1002/dneu.20954 – volume: 249 start-page: 424 year: 2002 ident: 10.1016/j.bbagen.2019.08.004_bb0180 article-title: Effects of nonenzymatic glycosylation of extracellular matrix components on cell survival and sensory neurite extension in cell culture publication-title: J. Neurol. doi: 10.1007/s004150200033 – volume: 129 start-page: 22 year: 2015 ident: 10.1016/j.bbagen.2019.08.004_bb0575 article-title: Pyridoxamine dihydrochloride in diabetic nephropathy (PIONEER-CSG-17): lessons learned from a pilot study publication-title: Nephron doi: 10.1159/000369310 – volume: 15 start-page: 1385 year: 2009 ident: 10.1016/j.bbagen.2019.08.004_bb0095 article-title: The extracellular matrix of blood vessels publication-title: Curr. Pharm. Des. doi: 10.2174/138161209787846757 – volume: 48 start-page: 29 year: 2013 ident: 10.1016/j.bbagen.2019.08.004_bb0235 article-title: Age-related expression, enzymatic solubility and modification with advanced glycation end-products of fibrillar collagens in mouse lung publication-title: Exp. Gerontol. doi: 10.1016/j.exger.2012.04.012 – volume: 173 start-page: 177 year: 1995 ident: 10.1016/j.bbagen.2019.08.004_bb0230 article-title: Age-related fluorescence in rat lung collagen publication-title: Lung doi: 10.1007/BF00175658 – volume: 275 start-page: 39027 year: 2000 ident: 10.1016/j.bbagen.2019.08.004_bb0040 article-title: Effect of collagen turnover on the accumulation of advanced glycation end products publication-title: J. Biol. Chem. doi: 10.1074/jbc.M006700200 – volume: 339 start-page: 31 year: 2010 ident: 10.1016/j.bbagen.2019.08.004_bb0070 article-title: Syndecans as receptors and organizers of the extracellular matrix publication-title: Cell Tissue Res. doi: 10.1007/s00441-009-0829-3 – volume: 3 start-page: 2941 year: 2013 ident: 10.1016/j.bbagen.2019.08.004_bb0535 article-title: Proteome wide reduction in AGE modification in streptozotocin induced diabetic mice by hydralazine mediated transglycation publication-title: Sci. Rep. doi: 10.1038/srep02941 – volume: 92 start-page: 248 year: 2013 ident: 10.1016/j.bbagen.2019.08.004_bb0290 article-title: Protein glycation during aging and in cardiovascular disease publication-title: J. Proteome doi: 10.1016/j.jprot.2013.05.012 – volume: 159 start-page: 333 year: 2001 ident: 10.1016/j.bbagen.2019.08.004_bb0125 article-title: Influence of non-enzymatically glycated collagen on monocyte-macrophage differentiation publication-title: Atherosclerosis doi: 10.1016/S0021-9150(01)00521-4 – volume: 26 start-page: 146 year: 2007 ident: 10.1016/j.bbagen.2019.08.004_bb0065 article-title: Mammalian collagen receptors publication-title: Matrix Biol. doi: 10.1016/j.matbio.2006.10.007 – volume: 2 start-page: 16 year: 2001 ident: 10.1016/j.bbagen.2019.08.004_bb0475 article-title: Non-enzymatic glycosylation of a type I collagen matrix: effects on osteoblastic development and oxidative stress publication-title: BMC Cell Biol. doi: 10.1186/1471-2121-2-16 – volume: 24 start-page: 32 year: 2004 ident: 10.1016/j.bbagen.2019.08.004_bb0565 article-title: Randomized trial of an inhibitor of formation of advanced glycation end products in diabetic nephropathy publication-title: Am. J. Nephrol. doi: 10.1159/000075627 – volume: 19 start-page: 573 year: 2009 ident: 10.1016/j.bbagen.2019.08.004_bb0165 article-title: Brain extracellular matrix in neurodegeneration publication-title: Brain Pathol. doi: 10.1111/j.1750-3639.2008.00195.x – volume: 7 start-page: 105 year: 2018 ident: 10.1016/j.bbagen.2019.08.004_bb0555 article-title: The effect of aminoguanidine (AG) and pyridoxamine (PM) on ageing human cortical bone publication-title: Bone Joint Res. doi: 10.1302/2046-3758.71.BJR-2017-0135.R1 – volume: 210 start-page: 100 year: 2016 ident: 10.1016/j.bbagen.2019.08.004_bb0335 article-title: Cross-linking versus RAGE: how do high molecular weight advanced glycation products induce cardiac dysfunction? publication-title: Int. J. Cardiol. doi: 10.1016/j.ijcard.2016.02.095 – volume: 22 start-page: 400 year: 2009 ident: 10.1016/j.bbagen.2019.08.004_bb0375 article-title: Highlights and hotspots of protein glycation in end-stage renal disease publication-title: Semin. Dial. doi: 10.1111/j.1525-139X.2009.00589.x – volume: 29 start-page: 559 year: 2009 ident: 10.1016/j.bbagen.2019.08.004_bb0610 article-title: Phase I clinical studies of the advanced glycation end-product (AGE)-breaker TRC4186: safety, tolerability and pharmacokinetics in healthy subjects publication-title: Clin. Drug Investig. doi: 10.2165/11315260-000000000-00000 – volume: 51 start-page: 2612 year: 2002 ident: 10.1016/j.bbagen.2019.08.004_bb0435 article-title: Effects of mesangium glycation on matrix metalloproteinase activities: possible role in diabetic nephropathy publication-title: Diabetes doi: 10.2337/diabetes.51.8.2612 – volume: 92 start-page: 392 year: 2011 ident: 10.1016/j.bbagen.2019.08.004_bb0255 article-title: Insulin modulates inflammatory and repair responses to elastase-induced emphysema in diabetic rats publication-title: Int. J. Exp. Pathol. doi: 10.1111/j.1365-2613.2011.00787.x – volume: 7 start-page: 4 year: 2014 ident: 10.1016/j.bbagen.2019.08.004_bb0370 article-title: The extracellular matrix in the kidney: a source of novel non-invasive biomarkers of kidney fibrosis? publication-title: Fibrogenesis Tissue Repair doi: 10.1186/1755-1536-7-4 – volume: 54 start-page: 72 year: 2009 ident: 10.1016/j.bbagen.2019.08.004_bb0605 article-title: TRC4186, a novel AGE-breaker, improves diabetic cardiomyopathy and nephropathy in Ob-ZSF1 model of type 2 diabetes publication-title: J. Cardiovasc. Pharmacol. doi: 10.1097/FJC.0b013e3181ac3a34 – volume: 46 start-page: 895 year: 1997 ident: 10.1016/j.bbagen.2019.08.004_bb0545 article-title: Progression of nephropathy in spontaneous diabetic rats is prevented by OPB-9195, a novel inhibitor of advanced glycation publication-title: Diabetes doi: 10.2337/diab.46.5.895 – volume: 269 start-page: 32299 year: 1994 ident: 10.1016/j.bbagen.2019.08.004_bb0415 article-title: Binding and modification of proteins by methylglyoxal under physiological conditions. A kinetic and mechanistic study with N alpha-acetylarginine, N alpha-acetylcysteine, and N alpha-acetyllysine, and bovine serum albumin publication-title: J. Biol. Chem. doi: 10.1016/S0021-9258(18)31635-1 – volume: 157 start-page: 1419 year: 2009 ident: 10.1016/j.bbagen.2019.08.004_bb0560 article-title: Prevention of arterial stiffening by pyridoxamine in diabetes is associated with inhibition of the pathogenic glycation on aortic collagen publication-title: Br. J. Pharmacol. doi: 10.1111/j.1476-5381.2009.00309.x – volume: 4 start-page: 19 year: 2012 ident: 10.1016/j.bbagen.2019.08.004_bb0135 article-title: Fibronectin glycation increases IGF-I induced proliferation of human aortic smooth muscle cells publication-title: Diabetol. Metab. Syndr. doi: 10.1186/1758-5996-4-19 – volume: 7 year: 2018 ident: 10.1016/j.bbagen.2019.08.004_bb0245 article-title: Nanoscale dysregulation of collagen structure-function disrupts mechano-homeostasis and mediates pulmonary fibrosis publication-title: Elife doi: 10.7554/eLife.36354 – volume: 58 start-page: 227 year: 2012 ident: 10.1016/j.bbagen.2019.08.004_bb0100 article-title: Molecular basis of arterial stiffening: role of glycation - a mini-review publication-title: Gerontology doi: 10.1159/000334668 – volume: 151 start-page: 991 year: 1988 ident: 10.1016/j.bbagen.2019.08.004_bb0530 article-title: Aspirin prevents the nonenzymatic glycosylation and carbamylation of the human eye lens crystallins in vitro publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/S0006-291X(88)80463-7 – volume: 40 start-page: 1144 year: 2007 ident: 10.1016/j.bbagen.2019.08.004_bb0455 article-title: Effects of non-enzymatic glycation on cancellous bone fragility publication-title: Bone doi: 10.1016/j.bone.2006.12.056 – volume: 13 year: 2018 ident: 10.1016/j.bbagen.2019.08.004_bb0445 article-title: Bone remodeling: a tissue-level process emerging from cell-level molecular algorithms publication-title: PLoS One doi: 10.1371/journal.pone.0204171 – volume: 52 start-page: 1435 year: 2014 ident: 10.1016/j.bbagen.2019.08.004_bb0630 article-title: Beneficial effect of Azadirachta indica on advanced glycation end-product in streptozotocin-diabetic rat publication-title: Pharm. Biol. doi: 10.3109/13880209.2014.895389 – volume: 12 start-page: 349 year: 2018 ident: 10.1016/j.bbagen.2019.08.004_bb0260 article-title: Inhalation therapy for repairing damaged elastin fibers and decelerating elastinolysis in chronic obstructive pulmonary disease publication-title: Expert Rev. Respir. Med. doi: 10.1080/17476348.2018.1460206 – volume: 91 start-page: 11704 year: 1994 ident: 10.1016/j.bbagen.2019.08.004_bb0380 article-title: Advanced glycation end products induce glomerular sclerosis and albuminuria in normal rats publication-title: Proc. Natl. Acad. Sci. U. S. A. doi: 10.1073/pnas.91.24.11704 – volume: 26 start-page: 865 year: 2015 ident: 10.1016/j.bbagen.2019.08.004_bb0460 article-title: Association between non-enzymatic glycation, resorption, and microdamage in human tibial cortices publication-title: Osteoporos. Int. doi: 10.1007/s00198-014-2938-4 – volume: 12 start-page: 228 year: 2013 ident: 10.1016/j.bbagen.2019.08.004_bb0010 article-title: Proteomic analysis of protease resistant proteins in the diabetic rat kidney publication-title: Mol. Cell. Proteomics doi: 10.1074/mcp.M112.020651 – volume: 123 start-page: 4195 year: 2010 ident: 10.1016/j.bbagen.2019.08.004_bb0050 article-title: The extracellular matrix at a glance publication-title: J. Cell Sci. doi: 10.1242/jcs.023820 – volume: 99 start-page: 373 year: 2016 ident: 10.1016/j.bbagen.2019.08.004_bb0500 article-title: Bone formation is affected by matrix advanced glycation end products (AGEs) in vivo publication-title: Calcif. Tissue Int. doi: 10.1007/s00223-016-0153-3 |
| SSID | ssj0000595 |
| Score | 2.4375465 |
| SecondaryResourceType | review_article |
| Snippet | Glycation driven generation of advanced glycation end products (AGEs) and their patho-physiological role in human degenerative diseases has remained one of the... |
| SourceID | proquest pubmed crossref elsevier |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 129411 |
| SubjectTerms | advanced glycation end products adverse effects Cellular signalling Degenerative diseases disease course drugs Extracellular matrix Extracellular Matrix Proteins - metabolism functional properties glycation Glycation End Products, Advanced - metabolism Glycosylation Humans integrins Organ Specificity pathogenesis Protein glycation RAGE receptors Signal Transduction tissues |
| Title | Glycation-induced modification of tissue-specific ECM proteins: A pathophysiological mechanism in degenerative diseases |
| URI | https://dx.doi.org/10.1016/j.bbagen.2019.08.004 https://www.ncbi.nlm.nih.gov/pubmed/31400438 https://www.proquest.com/docview/2271840670 https://www.proquest.com/docview/2388791413 |
| Volume | 1863 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB5VRQguCMprC1RG4mo2iZ045rZatSyg9gKVerPiR1BQN6nYrape-O3M2EkRElCJYyxbsjyTmc-exwfwRmeZL7XQPMSm2jbUnHAzb73NaydcnUfqhOOTanUqP56VZzuwnGphKK1ytP3JpkdrPY7Mx9OcX3Td_DMF9RBOEARBnKKoolxKRVr-9sevNA-ED2WKJEhOs6fyuZjjZS3-tNQFNdexkedI1_YH9_Q3-Bnd0NFDeDDiR7ZIW3wEO6Hfg7uJUfJ6D-4tJwK3x3D1_vw6PchxvHijCD1bD55Sg-IgG1q2jcfOqdySxtnh8pjFzg1dv3nHFoz4iof4-DHZSLYOVCvcbdas65kPX2PbarKZbIz1bJ7A6dHhl-WKjzwL3AldbnmjigbddCl9aSnKGArZIvCpM1-gqJwtnVMi96EUUnuEU62qQxCVDJl2lbNWPIXdfujDc2C2qQLeYApNffp1UzWVr2unqpaIr9BZzkBMx2vc2IScuDDOzZRt9s0koRgSiiGKzEzOgN-sukhNOG6ZrybJmd-UyaCfuGXl60nQBqVFwZOmD8PlxhSFostwpbJ_zBFosnWOuGAGz5KW3OxX5DJGXff_e28v4D59pULIl7C7_X4ZXiEi2tqDqPIHcGfx4dPq5Cdg2woH |
| linkProvider | Elsevier |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEB7SDSW9hDZ9bdKHCr2KtS3LsnJblqSbJruXJpCbsB4uLlk7dDeE_PtoZDml0DbQqyyB0Egznzya7wP4LJPEcskkdYFUW7uSIm6mtdVpaZgp0yCdsFgW84v86yW_3ILZUAuDzyqj7-99evDWsWUSV3Ny3TSTb5jU83ACIYjHKUI8gW1kp-Ij2J6enM6XvxwyD-Ir2J_igKGCLjzz0tqfWyRCTWXg8oyKbX-IUH9DoCESHT-H3QghybSf5QvYcu0ePO1FJe_2YGc2aLi9hNsvV3f9Pznq797eipasOouvg0Ij6WqyCStPseIS28nRbEECeUPTrg_JlKBkcRf-fwxukqwclgs36xVpWmLd98BcjW6TxHTP-hVcHB-dz-Y0Si1QwyTf0EpklY_UPLdcY6LRZXntsU-Z2Mxby2hujGCpdZzl0npEVYvSOVbkLpGmMFqz1zBqu9a9BaKrwvlLTCaRql9WRVXYsjSiqFH7ysfLMbBheZWJPOQoh3GlhgdnP1RvFIVGUaiSmeRjoA-jrnsejkf6i8Fy6rf9pHyoeGTkp8HQylsL8ydV67qbtcoygffhQiT_6MO815aphwZjeNPvkof5sjQPidf9_57bR9iZny_O1NnJ8vQAnuGXvi7yHYw2P2_cew-QNvpDPAD3dMQMuA |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Glycation-induced+modification+of+tissue-specific+ECM+proteins%3A+A+pathophysiological+mechanism+in+degenerative+diseases&rft.jtitle=Biochimica+et+biophysica+acta.+General+subjects&rft.au=Bansode%2C+Sneha+B&rft.au=Gacche%2C+Rajesh+N&rft.date=2019-11-01&rft.issn=0304-4165&rft_id=info:doi/10.1016%2Fj.bbagen.2019.08.004&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0304-4165&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0304-4165&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0304-4165&client=summon |